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INTRODUCTION 
Pfizer’s Chinese patent for Viagra was issued in late 2001.1  
Shortly thereafter, a number of Chinese companies filed requests in 
China’s State Intellectual Property Office (SIPO) to invalidate the 
patent.2  Viagra, one of the most successful prescription drugs ever 
launched in the United States, generates about one and a half 
billion dollars of annual sales in the U.S.3  With China’s market 
size, patent protection for Viagra in China means millions of 
dollars for Pfizer.  Because of the high stakes involved, this case 
took much longer time than usual.4  Finally, in early July 2004, the 
Patent Reexamination Board of SIPO declared the Chinese patent 
for Viagra invalid.5  Pfizer was “extremely disappointed” with this 
decision6 and has filed an appeal to the People’s Court.7 
The protection of intellectual property rights (IPR) in China 
has been an important issue for foreign companies that want to tap 
into China’s vast market, as well as for IPR holders in China.  The 
still relatively underdeveloped Chinese legal system and the lack 
of transparency in the legal proceedings are sources of concern for 
IPR holders.  In China, a civil law country, court decisions 
 
 1 See Liu Li, Patent on Viagra Faces Challenge, China Daily (Sept. 29, 2004), at 
http://www.chinadaily.com.cn/english/doc/2004-09/29/content_378513.htm. 
 2 Press Conference, Jing-chuan Wang, Director of SIPO (China Central Television 
(CCTV-9) broadcast, Apr. 12, 2004) (on file with author). 
 3 See, e.g., Al Branch, Jr., Competition for Viagra, PHARMACEUTICAL EXECUTIVE, at 
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=36725 (Nov. 1, 2002). 
 4 Wang, supra note 2. 
 5 See Guo Nei, Viagra Patent Found Invalid, China Daily (July 9, 2004), at 
http://www.chinadaily.com.cn/english/doc/2004-07/09/content_346788.htm. 
 6 See Intell. Prop. L. Bull., Pfizer, Trade Group Protest China’s Overturn of Viagra 
Patent (July 19, 2004), at http://www.iplawbulletin.com/cgi-bin/absolutenm-
/anmviewer.asp?a=1780. 
 7 See Nicole Ostrow, Pfizer Appeals China’s Decision to Overturn Patent on Viagra, 
BLOOMBERG NEWS SERVICE, at http://quote.bloomberg.com/apps-
/news?pid=10000087&sid=aEFUVtf_a498&refer=top_world_news (Sept. 28, 2004). 
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generally have no binding authority8 and are not regularly 
published as legal documents.9 
After China’s entry into the World Trade Organization (WTO) 
on December 11, 2001,10 however, China is expected to play by 
the WTO rules regarding IPR, mainly the Trade-Related Aspects 
of Intellectual Property Rights (TRIPS).11  One of the TRIPS 
requirements is that the resolution process of IPR disputes be 
transparent.12  On November 5, 2003, the Beijing High People’s 
Court, in a dramatic move, started to make available on the 
Internet judicial decisions on IPR cases handled by courts at 
various levels in Beijing.13  As of March 2004, more than 300 
 
 8 See Tianjin Court Issues China’s First Legal Precedents, XINHUA NEWS AGENCY, at 
http://www.china.org.cn/english/2003/Aug/71445.htm (Aug. 1, 2003).  But as China’s 
Xinhua News Agency reported, the Higher People’s Court of Tianjin, in a historical 
move, had issued three cases to which lower courts can refer in making judgments.  This 
is the first time a Chinese higher court has issued legal precedents. Id. 
 9 The Supreme People’s Court, the highest court in China, publishes some of its 
judgments in the Supreme Court Gazette.  These judgments have no binding authority.  
However, there presently is a tendency in China to try to give them some binding 
authority, largely as a result of the criticism of the inconsistency of courts’ statutory 
interpretations. Email to the author from Hon. George Q. Fu, Managing Partner, Watson 
& Band Law Offices, Shanghai, China (Feb. 4, 2004) (copy on file with author). 
 10 See Members and Observers, at http://www.wto.org/english/thewto_e/whatis_e-
/tif_e/org6_e.htm (last visited Oct. 22, 2004). 
 11 See generally Frequently Asked Questions about TRIPS, at 
http://www.wto.org/english/tratop_e/trips_e/tripfq_e.htm#Who’sSigned (last visited Oct. 
22, 2004) (stating that the TRIPS agreement applies to all WTO members). 
 12 See Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15, 
1994, Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, 
LEGAL INSTRUMENTS—RESULTS OF THE URUGUAY ROUND vol. 31, 33 I.L.M 81 (1994) pt. 
V, art. 63(1), available at http://www.wto.org/english/tratop_e/trips_e/t_agm0_e.htm 
(last visited Oct. 22, 2004) [hereinafter TRIPS Agreement].  “Laws and regulations, and 
final judicial decisions and administrative rulings of general application, made effective 
by a Member pertaining to the subject matter of this Agreement (the availability, scope, 
acquisition, enforcement and prevention of the abuse of intellectual property rights) shall 
be published, or where such publication is not practicable made publicly available, in a 
national language, in such a manner as to enable governments and right holders to 
become acquainted with them.” Id. 
 13 See Court Decisions Go Online in Beijing, XINHUA NEWS AGENCY, at 
http://www.china.org.cn/english/government/79383.htm (Nov. 6, 2003).  All of the 
judicial documents of the first and final judgments on IRP cases will be uploaded to the 
website http://bjgy.chinacourt.org. Id.  Confidential information or trade secrets that form 
part of the evidence of the IPR proceedings, however, are likely not to be published, in 
keeping with China’s Civil Procedure Law. See art. 66 of the Civil Procedure Law of 
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court decisions have been posted on that website, including patent, 
trademark, copyright, unfair competition, and technology contract 
cases.14  Among the patent cases posted, about 50% are appeals of 
patent invalidation decisions by the Patent Reexamination Board of 
SIPO.15 
With this new development, it is likely that the final decision 
on Pfizer’s appeal of the invalidation of the Viagra patent will be 
posted on the Internet, and one can examine it to see whether the 
interests of Pfizer (and those of the Chinese companies) are fairly 
protected.  Until the case is published, however, the reader may 
wonder: On what grounds can a person file a request for 
invalidation of a patent in China?16  More generally, what is the 
law and practice like in China regarding post-grant patent 
invalidation?  What are the differences and similarities between 
China’s patent invalidation proceeding and those of the United 
States, Europe and Japan?17  Why do we need a post-grant patent 
 
China (English translation), available at http://www.enonline.sh.cn/ILlook.asp?id=10285 
(last visited June 20, 2004). 
 14 See http://bjgy.chinacourt.org/cpws/index.php (last visited Nov. 19, 2004). 
 15 See id.  Readers familiar with the lack of usage of the American post-grant 
reexamination proceedings, might ask why China’s patent invalidation procedure is so 
frequently used—50% of the courts’ cases are about appeal of invalidation decisions?  In 
reality, the frequency of usage is much lower. See infra Part II.G.  The high percentage is 
due to the fact that the Beijing Intermediates Courts are the designated courts for appeals 
of SIPO invalidation decisions. See infra notes 56–57 and accompanying text. 
 16 It is not clear on exactly what grounds the Chinese companies had challenged the 
Viagra patent, but according to a leading official at SIPO, the patent had insufficient  
technological disclosure. See  Intell. Prop. L. Bull., China Defends Decision to Revoke 
Viagra Patent (Sept. 7, 2004), at http://www.iplawbulletin.com/cgi-
bin/absolutenm/anmviewer.asp?a=2109&z=13.  Such a ground, which largely relates to 
the written description and/or enablement requirements in the United States, would not 
have been a valid ground for invalidating a patent in the United States, where the 
patentability issues considered during reexamination are typically limited to novelty and 
obviousness. See infra notes 265, 335 and accompanying text; see also infra Part II.B for 
more details about the grounds for invalidation in China, which are broader than in the 
United States. 
 17 The law regarding post-grant patent invalidation, also known as opposition, 
reexamination, or revocation proceedings—depending on the country—has been very 
much in flux in recent years.  The United States, Japan, and China all amended relevant 
patent invalidation procedures in recent years. See infra Parts II–III.  In the United States, 
there are ongoing discussions of reform. See generally Fed. Trade Comm’n, To Promote 
Innovation: The Proper Balance of Competition and Patent Law and Policy 4, at 
http://www.ftc.gov/os/2003/10/innovationrpt.pdf (Oct. 2003) [hereinafter FTC Report]; 
SUN 1/25/2005  6:16 PM 
278 FORDHAM INTELL. PROP. MEDIA & ENT. L.J. [Vol. 15:273 
invalidation system, and what essential features should a good one 
have?  This paper attempts to address these questions.  A better 
understanding of the Chinese Patent Invalidation proceeding, 
particularly in comparison with the counterpart proceedings of the 
major Western countries, should help multinational companies like 
Pfizer to better protect their patent rights in China by adopting 
appropriate patent procurement and protection strategies. 
Part I of this paper provides as background a brief account of 
the development of IPR protection in China, particularly patent 
protection.  In Part II, the patent invalidation procedure in China is 
discussed.  Part III introduces the patent invalidation systems in the 
trilateral patent offices of Japan, the European Patent Convention 
(“EPC”), and the United States.  In Part IV, a brief discussion of a 
desirable post-grant invalidation system is presented, followed by a 
comparison of several key features of the Chinese system with 
their counterparts in the trilateral offices. 
I. PATENT LAW DEVELOPMENT IN CHINA AFTER 1978 
This section first briefly discusses the history of IPR legislation 
in China.  It then introduces the Chinese Patent Law, particularly 
the patentability provisions, which are important to the discussion 
of the Chinese patent invalidation system in Part II.  Finally, this 
section discusses the channels available for IPR dispute resolution 
in China, including the jurisdiction for patent invalidation 
proceedings. 
A. Brief History of IPR Legislation in China 
Over its long history, China did not develop a sustained 
indigenous intellectual property protection system, partly due to 
the character of its political culture, despite the fact that China’s 
civilization was, for centuries, one of the world’s most 
sophisticated, culturally, scientifically, and technologically.18  
 
Mark D. Janis, Rethinking Reexamination: Toward a Viable Administrative Revocation 
System for U.S. Patent Law, 11 HARV. J.L. & TECH. 1 (1997). 
 18 See WILLIAM P. ALFORD, TO STEAL A BOOK IS AN ELEGANT OFFENSE: INTELLECTUAL 
PROPERTY LAW IN CHINESE CIVILIZATION 2–3 (1995). 
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Attempts at the turn of the twentieth century to introduce European 
and American intellectual property law to China were 
unsuccessful.19  After its founding in 1949, the People’s Republic 
of China (PRC) began to establish an intellectual property 
protection regime based on the Soviet model.20  The fledgling 
intellectual property laws, however, were decimated, together with 
the entire legal system, by the Cultural Revolution of 1966–1976.21 
In 1978, China adopted the open-door policy.22  The next 
twenty years witnessed a dramatic cultural, economic, and political 
transformation in the Chinese society, as well as “a remarkable 
burst of legislative activity.”23  Today, some of China’s laws, 
including intellectual property (IP) laws, are rather close to those 
of developed Western nations.24  China has promulgated a full 
spectrum of IP-related laws and regulations, including, inter alia, 
Patent Law, Trademark Law, Copyright law, and Law Against 
Unfair Competition.25  These specific IP laws, together with the 
Constitution, the General Principles of Civil Law, the Civil 
Procedure Law, the Criminal Law, etc., form a complete system of 
IPR protection in China.26 
B. The Patent Law of China; Patentability Requirements 
The Patent Law of China (“Patent Law”) was first promulgated 
on March 12, 1984.27  It has since undergone two major revisions: 
 
 19 See id. 
 20 See id. at 56–63. 
 21 See id. at 63–65. 
 22 See Center for International Development, China Summary, at 
http://www.cid.harvard.edu/cidtrade/gov/chinagov.html (last updated Jan. 2004). 
 23 See, e.g., Jerome A. Cohen, The Chinese Legal System: A Primer for Investors, 17 
N.Y.L. SCH. J. INT’L & COMP. L. 345, 346–47 (1997). 
 24 See generally Michael N. Schlesinger, Intellectual Property Law in China: Part I—
Complying with Trips Requirements, 19 NO. 1 E. ASIAN EXECUTIVE REP. 9 (1997) 
(stating that “China is in substantial compliance with the TRIPS provisions on 
trademarks, patents and copyrights . . . .”). 
 25 See, e.g., Ping Zhang, The Development of China’s Intellectual Property Protection 
System, CASRIP NEWSLETTER (Center for Advanced Study and Res. on Intell. Prop., 
Seattle, WA.), Spring/Summer 1998, at http://www.law.washington.edu/casrip-
/newsletter/newsv5i2zhang.html. 
 26 Id. 
 27 See State Intell. Prop. Office of the P.R.C., Patent Law of the People’s Republic of 
China, http://www.sipo.gov.cn/sipo_English/flfg/zlflfg/t20020327_33872.htm (last 
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the first was in 1992,28 and the second in 2000.29  Implementing 
regulations were also promulgated.30  Among China’s IP laws, the 
Patent Law is considered the closest to being in complete 
compliance with TRIPS; any deviations are relatively minor.31 
Under the current Patent Law of China, there are three types of 
patents: patents for inventions, utility models and designs.32  
According to the Implementing Regulations of the Patent Law 
(“Implementing Regulations”), “invention” means any new 
technical solution relating to a product, a process or improvement 
thereof;33 “utility model” refers to any new technical solution 
relating to the shape, structure, or combination thereof, of a 
product that is fit for practical use;34 and “design” refers to any 
new design of the shape, pattern, color, or a combination thereof, 
of a product, which creates an aesthetic feeling and is fit for 
industrial application.35 
 
amended Aug. 25, 2000) [hereinafter Chinese Patent Law].  The author would like to 
caution the reader that the English translations of Chinese laws, including but not limited 
to IPR-related laws, which are available in books or on the internet, often contain 
inaccuracies or even mistakes, and therefore do not always accurately reflect the original 
meaning of the laws.  The reader is strongly advised not to rely solely on these English 
translations as legal authority in “real-life” situations, but to obtain advice from counsel 
well-versed in the relevant laws. 
 28 See Decision of the Standing Comm. of the Nat’l People’s Cong. on Amending the 
Patent Law of the People’s Republic of China, Laws of the People’s Republic of China 
1990–1992, Science Press, 1993, 501–18.  The amended law became effective January 1, 
1993. See id. 
 29 For an English translation of the current Patent Law of China, see Chinese Patent 
Law, supra note 27. 
 30 See State Intell. Prop. Office of the P.R.C., Implementing Regulations of the Patent 
Law of the People’s Republic of China, http://www.sipo.gov.cn/sipo_English-
/flfg/zlflfg/t20020327_33871.htm (effective July 1, 2001) [hereinafter Implementing 
Regulations]. 
 31 See Schlesinger, supra note 24, at 13–14 (“China has made great progress in recent 
years in creating a modern patent regime, one that both conforms with international 
intellectual property norms and complies with most of the major provisions of TRIPS on 
patents.”). 
 32 See Chinese Patent Law, supra note 27, art. 2 (“In this Law, ‘inventions-creations’ 
mean inventions, utility models and designs.”). 
 33 Implementing Regulations, supra note 30, Rule 2(1). 
 34 Id., Rule 2(2). 
 35 Id., Rule 2(3). 
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Regarding patentable subject matter, Article 5 of the Patent 
Law stipulates that “[n]o patent right shall be granted for any 
invention-creation that is contrary to the laws of the State or social 
morality or that is detrimental to public interest.”36  Also, no patent 
right shall be granted for any of the following: (1) scientific 
discoveries; (2) rules and methods for mental activities; (3) 
methods for the diagnosis or for the treatment of diseases; (4) 
animal and plant varieties; (5) substances obtained by means of 
nuclear transformation.37 
Regarding the basic requirements for the grant of patent right 
for an invention or utility model, Article 22 of the Patent Law 
provides: 
Any invention or utility model for which patent right[s] 
may be granted must possess novelty, inventiveness and 
practical applicability. 
Novelty means that, before the date of filing, no identical 
invention or utility model has been publicly disclosed in 
publications in the country or abroad or has been publicly 
used or made known to the public by any other means in 
the country, nor has any other person filed previously with 
the Patent Administration Department Under the State 
Council an application which described the identical 
invention or utility model and was published after the said 
date of filing. 
Inventiveness means that, as compared with the technology 
existing before the date of filing, the invention has 
 
 36 Chinese Patent Law, supra note 27, art. 5.  Similar provisions are found in EPC, 
infra note 194, art. 53:  
Exceptions to patentability: European patents shall not be granted in respect of: 
(a) inventions the publication or exploitation of which would be contrary to 
‘ordre public’ or morality, provided that the exploitation shall not be deemed to 
be so contrary merely because it is prohibited by law or regulation in some or 
all of the Contracting States; 
(b) plant or animal varieties or essentially biological processes for the 
production of plants or animals; this provision does not apply to 
microbiological processes or the products thereof. 
 37 Chinese Patent Law, supra note 27, art. 25.  But processes used in producing animal 
and plant varieties may be patentable. See id; see also EPC, infra note 194, art. 52. 
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prominent substantive features and represents a notable 
progress and that the utility model has substantive features 
and represents progress. 
Practical applicability means that the invention or utility 
model can be made or used and can produce effective 
results.38 
These requirements for patentability largely correspond to the 
U.S. requirements for novelty, non-obviousness, and utility,39 as 
well as the EPO requirements of novelty, inventive step, and 
industrial applicability.40 
The Patent Law has a special provision, in Article 24, for a six-
month grace period with respect to novelty, specifying three 
particular situations where the novelty of the patent application 
would not be affected: 
An invention-creation for which a patent is applied for does 
not lose its novelty where, within six months before the 
date of filing, one of the following events occurred:  
 (1) where it was first exhibited at an international 
exhibition sponsored or recognized by the Chinese 
Government; 
 (2) where it was first made public at a prescribed 
academic or technological meeting; 
 (3) where it was disclosed by any person without the 
consent of the applicant.41 
 
 38 Chinese Patent Law, supra note 27, art 22.  With regard to the patentability of a 
design, Article 23 of the Patent Law provides that: “Any design for which patent right[s] 
may be granted must not be identical with and similar to any design which, before the 
date of filing, has been publicly disclosed in publications in the country or abroad or has 
been publicly used in the country, and must not be in conflict with any prior right of any 
other person.” Id. art. 23. 
 39 See 35 U.S.C. §§ 101–103 (2003).  The United States provides a one-year grace 
period for the application after certain publication or disclosure of the invention. See id. 
§ 102(b); cf. infra note 41 and accompanying text. 
 40 See EPC, infra note 194, arts. 54–56.  A key difference is, of course, that the EPC 
does not provide for a six-month grace period. See infra note 41 and accompanying text. 
 41 Chinese Patent Law, supra note 27, art. 24. 
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Although this six-month grace period allows for the retention 
of novelty despite the disclosure of the invention in the three 
specified situations, the date of such disclosure does not constitute 
priority for a patent application claiming the disclosed invention.42  
Thus, if following an Article 24 disclosure, but before the inventor 
files a patent application over the disclosed invention, a third party 
independently files a patent application over the same invention, 
the “first-to-file” principle43 dictates that the inventor cannot obtain 
a patent.44  But the third party cannot obtain a patent either, 
because due to the Article 24 disclosure, the third party’s 
application lacks novelty.45 
C. Channels for IPR Dispute Resolution in China 
In China, IPR can be enforced both through administrative 
authorities and through the courts.46  The Patent Law, Trademark 
Law and Copyright Law of China all provide Chinese 
administrative authorities with the power for IPR enforcements.47  
In a case of patent infringement, administrative authorities may, 
sometimes ex officio, order an infringer to cease the infringing 
action and pay damages.48  Alternatively, a party whose patent has 
been infringed may sue the infringer directly in the People’s 
 
 42 See SIPO Guidelines for Patent Examination (hereinafter Guidelines), pt. II, ch. 3, § 
5.4.  This is the “MPEP” of China (“MPEP” is the Manual of Patent Examining 
Procedures of the United States Patent and Trademark Office).  The Guidelines embody 
the Patent Law and its Implementing Regulations, and are the basis for the Patent Office 
and the Patent Reexamination Board—two parallel and independent branches under the 
SIPO—to exercise their power.  The Guidelines has been translated into English by 
Helen Han of NTD Patent & Trademark Agency Limited, in THE GUIDELINES FOR 
PATENT EXAMINATION (2001), ISBN 962-7006-58-0. 
 43 See Chinese Patent Law, supra note 27, art. 9 (“Where two or more applicants file 
applications for patent for the identical invention-creation, the patent right shall be 
granted to the applicant whose application was filed first.”). 
 44 See Guidelines, supra note 42, pt. II, ch. 3, § 5.4. 
 45 See id. 
 46 See Michael N. Schlesinger, Intellectual Property Law in China: Part II—Evolving 
Judicial Role in Enforcement, 19 NO. 3 E. ASIAN EXECUTIVE REP. 9, 9 (1997). 
 47 See Chinese Patent Law, supra note 27, art. 57; Trademark Law of China, art. 41, 
available at http://www.sipo.gov.cn/sipo_English/flfg/default.htm (last visited Oct. 26, 
2004); Copyright Law of China, art. 47, available at http://www.sipo.gov.cn-
/sipo_English/flfg/default.htm (last visited Oct. 26, 2004). 
 48 See Schlesinger, supra note 46, at 11 (citing Chinese Patent Law, art. 60). 
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Courts.49  However, as detailed in Part II below, interested parties 
who want to challenge the validity of a patent must initiate the 
challenge through the patent invalidation procedure in SIPO. 
While historically administrative enforcement has played a 
more important role than judicial proceedings in resolving IPR 
disputes in China, the balance is gradually shifting.50  In July 1993, 
the Chinese government took an unprecedented step and 
established specialized IP divisions in the People’s Courts.51  
Currently, IP cases in China are largely handled by thirty-one 
Higher Courts and just over 300 Intermediate Courts around 
China.52  The No. 3 Civil Division of the Supreme People’s Court 
is the highest IP trial organ in China.53 
 
 49 See Chinese Patent Law, supra note 27, art. 57.  Criminal sanctions are also available 
in China for IPR infringement.  The Criminal Law of China provides seven counts of IP 
criminal offenses. See generally Schlesinger, supra note 46; see also Fu, infra note 52, at 
4.  Article 58 of the Patent Law provides that parties passing off another’s patented 
product as their own may be prosecuted under the Criminal Law, potentially leading to 
imprisonment, criminal detention, or criminal fines. See Chinese Patent Law, supra note 
27, art. 58.  In the two years from April 2001 to March 2002, Chinese courts took up 851 
IP criminal cases, implicating 1288 individuals.  During the same period, 775 criminal 
cases were finally adjudicated, implicating 1207 individuals.  Of these individuals, 143 
were sentenced to prison for five or more years (with the maximum prison term being 
seven years for IP criminal offenses in China), and 582 were sentenced to prison for less 
than five years. See Wang, supra note 2. 
 50 See Schlesinger, supra note 46, at 9–10.  The Chinese government has showed an 
apparent resolve to promote a shift from non-judicial to judicial enforcement of IPR. Id.  
Also, more and more IP holders seem to be willing to protect their IPR in China through 
judicial proceedings. 
 51 See id. 
 52 See Hon. George Fu, Recent Developments in China’s Judicial Protection of 
Intellectual Property Rights, Presentation at the International Intellectual Property Society 
(Dec. 18, 2003) (transcript on file with author).  The Chinese judicial system consists of 
the following courts at four levels: (1) Supreme People’s Court; (2) Higher People’s 
Court (each province, autonomous region, or municipality directly under the authority of 
the central government, has one Higher People’s Court); (3) Intermediate People’s Court 
(each major city has one or two Intermediate People’s Courts); and (4) Basic People’s 
Court (each county and each district of major cities has one Basic People’s Court).  China 
adopts a “two-instance” trial system.  In most cases, Intermediate Courts are the first 
instance courts for IPR cases. See CCPIT Patent and Trademark Law Office, 
Enforcement of Intellectual Property Rights - Judicial System, at http://www.ccpit-
patent.com.cn/ip_forms/IP_Enforcement.htm#a1 (last visited Oct. 25, 2004). 
 53 See Fu, supra note 52, at 2. 
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IPR administrative decisions are subject to judicial review by 
the People’s Courts.54  For example, a party who is dissatisfied 
with an initial ruling in an administrative proceeding on patent 
infringement may appeal to Intermediate People’s Courts at the 
provincial level or other Intermediate People’s Courts specially 
designated by the Supreme People’s Court.55  For cases concerning 
whether an IP right should be granted, or whether a granted IP 
right should be revoked, however, the Supreme People’s Court has 
granted the Beijing Intermediate Courts exclusive jurisdiction.56  
Thus, a patent holder dissatisfied with the invalidation of his patent 
by the SIPO Patent Reexamination Board will have to appeal the 
decision to the Beijing Intermediate Courts.57 
II. POST-GRANT PATENT INVALIDATION IN CHINA 
In discussing the patent invalidation procedure in SIPO, this 
section will address the following aspects in succession: a brief 
history of the patent-invalidation system; when, by whom, and on 
what grounds can requests for invalidation be filed; the 
composition of the Reexamination Board; opportunity for 
participation by the parties involved (including oral proceedings); 
possible outcomes of the reexamination and their effects; appeal 
procedure; and statistics of usage of the invalidation procedure. 
 
 54 See id. at 4. 
 55 See id. at 2. 
 56 See id.  The Beijing Intermediate Courts’ exclusive jurisdiction also includes matters 
involving compulsory licensing. Id. 
 57 Therefore, although the post-grant patent invalidation procedure at SIPO is used 
relatively frequently (see infra Part II.G), it is not that 50% of all the patent-related suits 
in Chinese courts are appeals from patent invalidation decisions of the Patent 
Reexamination Board.  This percentage applies only to the Beijing Intermediate People’s 
Courts, but not to all the People’s Courts across China. See supra note 15 and 
accompanying text. 
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A. History of Patent Opposition/Invalidation Provisions in the 
Patent Law 
Before it was amended in 1992, the Chinese Patent Law 
provided for a pre-grant opposition procedure.58  In the 1992 
amendment, this pre-grant opposition was abolished and replaced 
by post-grant opposition (or revocation).59  This change shortened 
the time required to grant a patent by six to ten months, depending 
on the type of patent application.60  Thus, before the 2000 
amendment, the Patent Law provided for both a post-grant 
opposition and a post-grant invalidation procedure.61  The two 
procedures serve essentially the same function and there existed an 
overlap.62  The differences between the two lay in the time allowed 
for filing a claim, the grounds on which the revocation or 
invalidation claim can be based, and the authorities that will accept 
the claim.63  Experience demonstrated that the post-grant 
opposition procedure added to SIPO’s burden of examination.64  
Also, the invalidation procedure cannot begin until the opposition 
procedure ends, and this could adversely affect a concerned party’s 
interest.65  To address these problems, the 2000 amendment of the 
Patent Law eliminated the post-grant opposition procedure.66  
Consequently, under the current Patent Law, the invalidation 
procedure is the single mechanism for challenging a patent’s 
validity.67  This approach is considered to be consistent with the 
requirements of TRIPS.68 
 
 58 See East IP Group, The Latest Amendments to the Chinese Patent Law - A 
Comparative Study of the Patent Law with the TRIPS Agreement, at 
http://www.eastip.com/news_publications/latestamendment (Oct. 17, 2001). 
 59 See id.  Although the pre-grant opposition procedure is eliminated, one may, from 
the date a patent application is published, until the date the patent right is granted, submit 
to the SIPO one’s observations that the application is not in conformity with the 
provisions of the Patent Law. See Implementing Regulations, supra note 30, Rule 48. 
 60 See East IP Group, supra note 58. 
 61 See id. 
 62 See id. 
 63 See Zhang, supra note 25. 
 64 See East IP Group, supra note 58. 
 65 See Zhang, supra note 25. 
 66 See East IP Group, supra note 58. 
 67 See id. 
 68 See id. 
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B. Request for Invalidation and Grounds Therefore 
Once a patent is granted, any person (either an individual or an 
entity) who believes that the patent should not have been granted 
pursuant to the Patent Law, can request that the Patent 
Reexamination Board declare the patent invalid.69  There is no 
requirement in the Patent Law that the identity of the true party in 
interest be disclosed. 
The request for invalidation shall state in detail the grounds for 
filing the request, by specifying the sections or articles of the 
Patent Law or the Implementing Regulations, and provide 
evidence for each ground.70  Rule 64(2) of the Implementing 
Regulations provides a list of grounds on which an invalidation 
request can be based.71  Such grounds include issues relating to, 
inter alia,  (1) novelty, inventiveness, and practical applicability;72 
(2) enablement and written description;73 (3) amendments that go 
beyond the scope of the patent application’s original disclosure;74 
(4) whether the subject matter is patentable;75 (5) double 
patenting;76 and (6) formal matters.77  Thus, the grounds for 
invalidation in China are much broader than those available in the 
 
 69 See Chinese Patent Law, supra note 27, art. 45. 
 70 See Implementing Regulations, supra note 30, Rule 64(1); Guidelines, supra note 42, 
pt. IV, ch. 3, § 3.1. 
 71 Implementing Regulations, supra note 30, Rule 64(2) (“The grounds on which the 
request for invalidation is based . . . mean that the invention-creation for which the patent 
right is granted does not comply with the provisions of Article 22, Article 23, or of 
Article 26, paragraph three or four, or of Article 33 of the Patent Law, or of Rule 2, or of 
Rule l3, paragraph one, or of Rule 20, paragraph one, or of Rule 21, paragraph two of 
these Implementing Regulations; or the invention-creation falls under the provisions of 
Articles 5 or 25 of the Patent Law; or the applicant is not entitled to be granted the patent 
right in accordance with the provisions of Article 9 of the Patent Law.”). 
 72 See Chinese Patent Law, supra note 27, art. 22. 
 73 See id. art. 26. 
 74 See id. art. 33. 
 75 See id. arts. 5, 25; Implementing Regulations, supra note 30, Rule 2. 
 76 See Implementing Regulations, supra note 30, Rule 13(1). 
 77 See, e.g., id. Rule 20(1) (“The claims shall define clearly and concisely the matter for 
which protection is sought in terms of the technical features of the invention or utility 
model.”); cf. 35 U.S.C. § 112, ¶ 2 (2003) (“The specification shall conclude with one or 
more claims particularly pointing out and distinctly claiming the subject matter which the 
applicant regards as his invention.”). 
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United States.78  As mentioned supra in Part I.B, under the Patent 
Law of China, “[n]ovelty means that, before the date of filing, no 
identical invention . . . has been publicly disclosed in publications 
in the country or abroad or has been publicly used or made known 
to the public by any other means in the country.”79  This is in sharp 
contrast with the practice in the United States, where grounds for 
questioning the validity of a patent—a substantial new question of 
patentability—must be based on patents or printed publications.80 
C. The Patent Reexamination Board 
The Patent Reexamination Board is composed of a Director, a 
Deputy Director, Members, and Examiners for Reexamination.81 
The position of Director is held by the Commissioner of SIPO.82  
The Deputy Director and the Members are appointed by the 
Commissioner from experienced technical and legal experts of 
SIPO.83  Examiners for Reexamination are experienced examiners 
and legal staff selected from SIPO.84 
An invalidation case can be handled by a collegiate panel or by 
a sole examiner.85  A collegiate panel consists of three to five 
members, including a panel leader, one chief examiner and one or 
three associate examiners.86  A five-person panel shall be used, as 
determined or approved by the Director of the Board, if the case 
(1) has great impact in China and abroad, (2) involves important or 
difficult legal issues, or (3) involves great economic interests.87  
 
 78 See infra Part III.C.2.a for grounds for requesting patent reexamination in the United 
States. 
 79 See Chinese Patent Law, supra note 27, art. 22(2) (emphasis added). 
 80 See infra Part III.C; see also infra Part IV, regarding the meaning under the Patent 
Law of China of “public disclosure,” which includes disclosure by publication and non-
publication disclosure. 
 81 See Guidelines, supra note 42, pt. IV, ch. 1, § 4. 
 82 See id. 
 83 See id. 
 84 See id. 
 85 See id. §§ 6–7. 
 86 See id. § 6. 
 87 See id. § 6.2.  The Viagra case is clearly a case that involved great economic 
interests.  Indeed, SIPO had established a special committee to examine the case. See 
Pfizer Says China Has Overturned Viagra Patent, ASSOCIATED PRESS, 
http://www.forbes.com/business/feeds/ap/2004/07/07/ap1446796.html (July 7, 2004). 
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An opinion of a collegiate panel is reached through voting, 
wherein the majority opinion controls.88  Simple cases may be 
examined independently by a single examiner.89  A member of the 
Patent Reexamination Board shall be excluded from the 
invalidation proceedings if he is deemed an interested party or was 
involved in the original examination of the application from which 
the patent issued.90 
D. Conduct of the Reexamination 
In conducting the reexamination of a patent, the Reexamination 
Board shall abide by the principles of legality, fairness, petition, 
hearings, and publicity.91  The principle of legality requires that the 
reexamination procedure and decision conform to applicable laws 
and rules;92 the principle of fairness requires the Board to reach a 
decision objectively, correctly, and timely, based on the facts and 
the law;93 the principle of petition allows the person who has filed 
the request for invalidation to withdraw the case before the Board 
has reached a decision;94 the principle of hearings allows the party 
to whom a determination is unfavorable an opportunity to provide 
observations against the grounds, evidence or affirmed facts 
adopted in the decision;95 and the principle of publicity requires 
that, except for cases that should be kept confidential according to 
law, oral hearings be held publicly and the decision of the 
reexamination be published.96 
The reexamination is inter partes in nature.  The Board will 
send a copy of the request for invalidation and relevant 
 
 88 See Guidelines, supra note 42, pt. IV, ch. 1, § 6.4. 
 89 See id. § 7. 
 90 See id. § 8; see also Implementing Regulations, supra note 30, Rule 38. 
 91 See generally Guidelines, supra note 42, pt. IV, ch. 1, § 5. 
 92 See id. § 5.1. 
 93 See id. § 5.2. 
 94 See id. § 5.3.  The petitioner who requested the invalidation, however, cannot 
withdraw the case after the Board has announced or issued a decision in writing.  Such a 
decision is binding notwithstanding the attempt by petitioner to withdraw the case. Id. 
 95 Id. § 5.5. 
 96 Id. §§  5.6, 9.3. 
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documents97 to the patent owner,98 and invite the patent owner to 
respond within a specified time limit,99 which is usually within a 
month100 and not extendible.101  Depending on the circumstances 
of the reexamination, the Board may also transfer to the person 
requesting the invalidation any observations filed by the patentee 
in response to the request for invalidation, and, when necessary, set 
a time limit (usually one month) for response.102  If a party fails to 
respond within the time limit, the party will be deemed to have 
known the grounds, facts and evidence contained in the transferred 
documents and to have raised no opposition.103 
The Board may also conduct investigations ex officio on the 
case.104  In general, however, the Board will conduct the 
reexamination only on the grounds that the requester raises and is 
not obliged to perform a comprehensive examination of the 
validity of the challenged patent.105   
The patentee is permitted to amend the claims of the patent, 
provided that such amendment does not broaden the scope of 
patent protection.106  The patentee, however, cannot amend the 
description or drawings of the patent.107  If the amendment of the 
claims is done by means other than deletion, the person requesting 
 
 97 Within one month after the filing date of the request for reexamination, the person 
making the request may supply additional evidence or arguments. See Implementing 
Regulations, supra note 30, Rule 66. 
 98 Id.  The terms “patent owner,” “patentee,” and “the proprietor of the patent” (and 
variations thereof) are used interchangeably in this paper, although their legal meanings 
are not exactly the same. 
 99 See Implementing Regulations, supra note 30, Rule 67(1). 
 100 See Guidelines, supra note 42, pt. IV, ch. 3, § 5.1. 
 101 See Implementing Regulations, supra note 30, Rule 70 (“In the course of the 
examination of a request for invalidation, the time limit specified by the Patent 
Reexamination Board shall not be extended.”). 
 102 See Guidelines, supra note 42, pt. IV, ch. 3, § 5.1; see also Implementing 
Regulations, supra note 30, Rule 67(2). 
 103 Guidelines, supra note 42, pt. IV, ch. 3, § 5.1. 
 104 Guidelines, supra note 42, pt. IV, ch. 1, § 5.4. 
 105 See Guidelines, supra note 42, pt. IV, ch. 3, § 3.1.2. 
 106 See Implementing Regulations, supra note 30, Rule 68(1). 
 107 See id. Rule 68.  The drawings, photographs, or the brief explanation of a design 
patent cannot be amended. Id. 
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the invalidation is given an opportunity to raise new grounds, 
evidence and observations against the amended claims.108 
The Board may, at the request of the parties or at its discretion 
based on the needs of the case, decide to hold oral hearings during 
the reexamination process.109  A party shall submit the request for 
oral hearing in writing, setting forth the grounds for such 
request.110  As already mentioned, the oral hearings shall be 
conducted publicly, subject to situations where confidentiality is 
required by law.111  To guarantee fairness, a member of the Panel 
usually cannot interview with only one side to the 
reexamination.112 
E. Outcomes of the Invalidation Proceeding and Their Effects 
An invalidation proceeding may take up to two years,113 with 
three possible outcomes: (1) the entire patent is declared invalid; 
(2) part of the patent is declared invalid; and (3) the patent is 
upheld.114  Any patent right (or part thereof) that has been declared 
invalid is deemed to have not existed from the beginning.115  The 
claims (including amended claims) of a patent that is upheld are 
deemed to have existed from the very beginning.116 
Importantly, a decision by the Board declaring a patent invalid 
will not have retroactive effect on any judgment of patent 
 
 108 See Guidelines, supra note 42, pt. IV, ch. 3, § 5.4. 
 109 See Implementing Regulations, supra note 30, Rule 69(1).  In a case before a five-
person panel, oral hearings shall be conducted if such hearings have not been conducted 
previously in the case before the five-person panel is established. See Guidelines, supra 
note 42, pt. IV, ch. 1, § 6.2.  By inference, oral hearings—which would have been 
public—had probably been conducted in the Viagra case, because it was handled by a 
special panel. See supra note 87. 
 110 The grounds for requesting an oral hearing may include: “(1) one party wishes to 
have a face-to-face cross-examination and argument with the adversary; (2) it is 
necessary to state the facts before the Panel; (3) it is necessary to make [a] demonstration 
in kind; (4) it is necessary to present witnesses to testify.” See Guidelines, supra note 42, 
pt. IV, ch. 4, § 2. 
 111 See Guidelines, supra note 42, pt. IV, ch. 5, § 5.2. 
 112 See Guidelines, supra note 42, pt. IV, ch. 3, § 3.6. 
 113 See East IP Group, supra note 58. 
 114 Guidelines, supra note 42, pt. IV, ch. 3, § 6. 
 115 See Chinese Patent Law, supra note 27, art. 47(1); Guidelines, supra note 42, pt. IV, 
ch. 3, § 6. 
 116 See Guidelines, supra note 42, pt. IV, ch. 3, § 6. 
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infringement that has been pronounced and enforced by the 
People’s Court, or on contracts relating to licensing or assignment 
of patent rights that have been performed before the declaration of 
the patent’s invalidity.117  But the patent owner will be liable for 
damages caused to other parties due to its bad faith.118  Also, the 
original owner of the now invalid patent should repay a licensee or 
an assignee the whole or part of the patent licensing or assignment 
fees if not doing so would be contrary to the principle of equity.119 
Because post-grant patent invalidation proceedings must be 
initiated at the SIPO Patent Reexamination Board,120 and because 
the Beijing People’s Intermediate Courts are the designated courts 
for appeal of the Board’s decision, a situation can arise where a 
patent is affirmed to be invalid in the Beijing Intermediate Courts, 
but the same patent is found infringed in another People’s Court 
elsewhere in China.121  Thus, when an invalidation request has 
been filed in the SIPO, it is a critical issue whether to stay an 
infringement proceeding in a court other than the Beijing 
Intermediate Courts.122  A Supreme Court circular issued before 
the 2000 amendment of the Patent Law suggested that the courts 
have the discretion (but not the obligation) to order a stay if 
invalidation proceedings are pending in the SIPO.123  In 
infringement cases involving utility models and designs, such a 
stay is almost automatic.  In invention patent cases, however, stays 
are not as common.124  One explanation for this differential 
treatment is that, because invention patents, unlike utility model or 
design patents, are only granted after substantive examination, the 
People’s Court can proceed with the infringement hearing 
 
 117 See Chinese Patent Law, supra note 27, art. 47(2). 
 118 See id. 
 119 See id., art. 47(3). 
 120 Pursuant to Articles 41, 45 and 46 of the Patent Law, the Patent Reexamination 
Board performs examinations of requests for invalidation of granted patents (as well as 
requests for reexamination of the Patent Office’s decision on examination of patent 
applications). See Guidelines, supra note 42, pt. IV, ch. 1, § 3. 
 121 See East IP Group, supra note 58. 
 122 See id. 
 123 See id. 
 124 See id.; see also John Richards, Guide to Patent Protection in the Pacific Rim 20 
(Spring 2004) (unpublished manuscript, on file with author). 
SUN 1/25/2005  6:16 PM 
2004] POST-GRANT PATENT INVALIDATION 293 
involving an invention patent with the presumption that the 
invention patent is valid.125 
On the other hand, the Reexamination Board should 
temporarily suspend the invalidation proceedings if the People’s 
Court has ordered a patent right preservation concerning the 
challenged patent and has requested the Board to assist exercising 
the preservation of the patent right.126  Temporary suspension of 
the invalidation proceedings will also be effected when there is a 
dispute over the ownership of the patent right and a party involved 
in the dispute requests suspension of the invalidation 
proceedings.127  The Board can resume the invalidation 
proceedings if, inter alia, (1) the party that requested suspension 
now requests restoration of the proceedings; (2) no request to 
extend the suspension has been received after one year of 
suspension based on a patent right ownership dispute; or (3) the 
People’s Court has issued no order to continue the preservation of 
patent right after the expiration of the time limit for 
preservation.128 
F. Appeal 
Before the 2000 amendment, a decision by the Board regarding 
the validity of a utility model or design patent was final, while a 
decision by the Board on the validity of an invention patent was 
subject to appeal.129  To comply with TRIPS, which requires that 
administrative decisions in any proceeding for the acquisition and 
maintenance of intellectual property rights be subject to judicial 
review,130 the 2000 amendment removed the finality of the Board’s 
decision on the validity of the patent right for utility models and 
designs.131 
 
 125 See East IP Group, supra note 58. 
 126 See Implementing Regulations, supra note 30, Rule 87; Guidelines, supra note 42, 
pt. IV, ch. 3, § 5.5. 
 127 See Implementing Regulations, supra note 30, Rule 86; Guidelines, supra note 42, 
pt. IV, ch. 3, § 5.5. 
 128 See Implementing Regulations, supra note 30, Rule 86–87; Guidelines, supra note 
42, pt. IV, ch. 3, § 5.5. 
 129 See East IP Group, supra note 58. 
 130 See TRIPS Guidelines, supra note 12, art. 62, ¶ 5. 
 131 See East IP Group, supra note 58. 
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Under the current Patent Law, any party not satisfied with the 
decision of the Board may, within three months from receipt of the 
notification of the decision, appeal to the People’s Court.132  As 
mentioned earlier, the appeal will be taken up at the Beijing 
Intermediate People’s Courts.133  The SIPO Patent Reexamination 
Board is the defendant in the appeal.134  The Court will notify the 
party who opposed the now appellant in the invalidation 
proceedings to appear as a third party.135  A party dissatisfied with 
the Intermediate Court’s decision can further appeal to the Beijing 
Higher People’s Court.136 
If the decision of the Reexamination Board has been 
withdrawn by a valid People’s Court judgment but the court does 
not enter its own ruling on the validity of the patent, the Board will 
need to re-conduct the invalidation proceedings.137  If the Board’s 
original decision has been withdrawn by the court for insufficient 
evidence or erroneous application of law during the invalidation 
proceedings, the Board cannot, in reexamining the invalidation 
case, reach the same decision based on the same evidence or 
reasoning.138  If the original Board decision has been withdrawn 
for procedural errors, the Board shall re-examine the invalidation 
case based on the correct procedures as determined by the People’s 
Court.139 
G. Statistics on the Use of the Invalidation System 
According to the 2002 Annual Report of SIPO, “[s]ince 1985, 
the Patent Re-examination Board [has] received 8594 requests for 
 
 132 See Chinese Patent Law, supra note 27, art. 46(2). 
 133 See supra note 52 and accompanying text. 
 134 See Guidelines, supra note 42, pt. IV, ch. 3, § 5.6. 
 135 See Chinese Patent Law, supra note 27, art. 46(2).  Thus, in the Viagra case, the 
appeal will be Pfizer v. SIPO Patent Reexamination Board, with the Chinese companies 
that requested the invalidation participating as third parties. 
 136 For an illustration of the appeal procedures, see Chinese Patent Agent (H.K.) Ltd., 
Buhler A.G. v. Patent Reexamination Board, at http://www.cpahkltd.com/publications-
/cases/ebuhle.html (last visited Oct. 25, 2004) (brief description of case). 
 137 See Guidelines, supra note 42, pt. IV, ch. 1, § 13.1.2. 
 138 See id. § 13.2. 
 139 See id. § 13.3. 
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invalidation.140  In 2002, 1752 requests for invalidation were 
received, 436 more than in the previous year, representing an 
increase of 33.1%.141  Of [the] requests received in 2002, 130 
related to invalidation requests for invention patents, accounting 
for 7.4% of the total, 756 related to invalidation requests for utility 
models, accounting for 43.2%, and 866 to industrial designs, 
making up the remaining 49.4%.”142  In 2002, about 132,500 
patents were granted in China, with about 21,500 for inventions, 
57,500 for utility models, and 53,500 for industrial designs.143  
Thus the number of requests for invalidation in 2002 represents 
just over 1.3% of the number of patents granted in 2002.144 
According to the 2002 Annual Report, since 1985, 352 cases 
have been lodged with the Beijing Number One Intermediate 
People’s Court due to dissatisfaction with invalidation decisions 
made by the Patent Reexamination Board.145  In 2002 alone, 211 
appeals were brought to the Beijing Number One Intermediate 
People’s Court (or to the Beijing High People’s Court), of which 
twenty-five were against the invalidation decisions involving 
invention patents, 116 involving utility model patents, and seventy 
involving industrial designs.146  Evidently, the total number of 
appeals increased dramatically in 2002, exceeding the total number 
of appeals from 1985 to 2001.  This is clearly the result of the 2000 
amendment to the Patent Law—effective July 1, 2001—that allows 
 
 140 State Intell. Prop. Office of the P.R.C., ANN. REP. 2002, Chapter V: Reexamination 
and Invalidation, at http://www.sipo.gov.cn/sipo_English/ndbg/nb/ndbg2002/default.htm  
(last visited Oct. 25, 2004) [hereinafter Annual Report 2002]. 
 141 Id.  This increase may not necessarily mean that the post-grant invalidation process is 
gaining popularity.  Rather, it is likely the result of the rapidly growing number of patent 
applications and grants in China. See generally Intell. Prop. L. Bull., Boom for Patent 
Application in China (Mar. 25, 2004), at http://www.iplawbulletin.com/cgi-
bin/absolutenm/anmviewer.asp?a=1180; Annual Report 2002, supra note 140, at ch. II, 
§ 4 (“Chapter II: Patent Application and Examination”). 
 142 Annual Report 2002, supra note 140, ch. V. 
 143 Annual Report 2002, supra note 140, ch. II, § 4. 
 144 The real percentage of patents subject to invalidation requests is likely higher than 
1.3%, because many of the requests in 2002 are against patents issued before 2002; the 
percentage is also likely growing because now requesters of invalidation of utility model 
and design patents can appeal an unsatisfactory decision by the Reexamination Board 
(see supra note 131 and accompanying text). 
 145 Annual Report 2002, supra note 140, ch. V. 
 146 Annual Report 2002, supra note 140, ch. V. 
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for appeals of the Board’s invalidation decisions involving utility 
model and design patents,147 which constitute the vast majority of 
the invalidation proceedings.148 
III. POST-GRANT PATENT INVALIDATION IN THE TRILATERAL 
OFFICES 
This section examines the systems for challenging the validity 
of granted patents in the trilateral patent offices of Japan, the EPO, 
and the United States.  The major aspects of each of these 
invalidation systems are discussed in largely the same sequence as 
for the Chinese system. 
A. Japan 
1. Brief History of the Japanese Patent Invalidation System 
The Japanese law on challenging a granted patent in the Japan 
Patent Office (JPO) has been recently revised.  Before 1996, an 
interested party could challenge the grant of a patent or a granted 
patent through pre-grant opposition or a patent invalidity trial.149  
Because the pre-grant opposition procedure caused delays in the 
issuance of patents and resulted in undue harassment of the 
applicant, it was terminated in 1996 and replaced with post-grant 
opposition.150  All the opposition or invalidation proceedings were 
to be conducted within the JPO, which had exclusive (first-
instance) jurisdiction over all issues relating to the validity of a 
Japanese patent.151  While this is still largely true, in April 2000, 
the Supreme Court of Japan in Texas Instruments, Inc.  v. Fujitsu 
 
 147 See supra note 131 and accompanying text. 
 148 See supra note 142 and accompanying text. 
 149 See generally Setsuko Asami, The New Patent Office Trial of Invalidity: 
Administrative Patent Trials under the 2003 Amendments to the Japanese Patent Law, at 
2–4, paper presented at the Eleventh Annual Conference on International Intellectual 
Property Law & Policy, Fordham University School of Law, Apr. 24 & 25, 2003, New 
York City. 
 150 See, e.g., Gerald J. Mossinghoff and Vivian S. Kuo, Post-Grant Review of Patents: 
Enhancing the Quality of the Fuel of Interest, 85 J. PAT. & TRADEMARK OFF. SOC’Y 231, 
247; Asami, supra note 149, at 2–3. 
 151 See Mossinghoff and Kuo, supra note 150, at 247. 
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Ltd.152 held that “[even] before the decision invalidating a patent 
has become final [at the JPO], where a court determines that there 
has been infringement of a patent, it should determine whether any 
reason for invalidity exists,” and that a patent is invalid if there are 
obvious reasons for invalidity and if there is a high level of 
certainty that the JPO would invalidate the patent at an invalidation 
trial.153 
Post-grant opposition, introduced partly as a result of 
discussions between the United States Patent and Trademark 
Office (USPTO) and the JPO,154 had its own problems.  A post-
grant opposition is not inter partes, but ex parte, precluding the 
party who challenges the validity of the patent from 
participation.155  The true party in interest must be identified in the 
opposition156 and the opposition must be filed within six months of 
the patent’s issue date.157  Due to the ex parte nature of the post-
 
 152 This case is also known as the “Kilby case.”  An English translation of the case is 
available at http://www.softic.or.jp/en/cases/Texas_Inst_v_Fujitsu.html (last visited Oct. 
25, 2004). 
 153 See Judge Shuhei Shiotsuki, Invalidation Procedure and Infringement Trials in 
Japanese Courts and Patent Office, in 7 CASRIP PUBLICATION SERIES, RECONCILING 
INTERNATIONAL INTELLECTUAL PROPERTY 87, 88–89, http://www.law.washington.edu-
/casrip/Symposium/Number7/2B-Shiotsuki.pdf (July 2002); see also Ladas & Parry LLP, 
Japan – Consideration of Validity of Patent in Infringement Action, at 
http://www.ladas.com/BULLETINS/2002/0202Bulletin/JapanValidityInInfrigement.html 
(Feb. 2002) (“In Japan the law provides that matters relating to the validity of patents 
should be dealt with by nullity proceedings initiated before the Patent Office.  Invalidity 
of the patent being sued upon is not in itself a defense to an infringement lawsuit in 
Japan, although on occasion, courts have construed patents narrowly in cases where they 
have felt the patent unlikely to be valid.  As a practical matter, this situation may be about 
to change.  In April 2000 in Texas Instruments v. Fujitsu Ltd. the Japanese Supreme 
Court held that, in cases where a court hearing an infringement action concluded that it 
was highly likely that the patent was invalid, it could decline to enforce it, since any such 
enforcement would be a misuse of the patent right.  It therefore appears that defendants 
will now have a clear interest in raising issues of invalidity when sued for patent 
infringement.  The case in which the issue arose was one where the ground of invalidity 
in question was the Japanese equivalent of double patenting and was fairly easy for the 
court to understand.  Whether courts will be willing to consider issues of obviousness or 
other more complex allegations of invalidity in infringement trials remains to be seen.  In 
such cases it may still be necessary to use the traditional route of a nullity suit.”). 
 154 See Asami, supra note 149, at 2–3. 
 155 See id. at 3. 
 156 See id. n.3. 
 157 See id. at 3. 
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grant opposition procedure, the party challenging the patent lost 
about 80% of all oppositions.158  Furthermore, the party losing the 
opposition to the patentee has no right of appeal to the Tokyo High 
Court.159  Consequently, the total number of oppositions declined 
from 6000 in 1998 to about 3500 in 2001, representing 
approximately three percent of all granted patents.160  The number 
of invalidation trials, however, has remained constant, at just 
below 0.3% of all granted patents.161 
Because of the dual opposition and invalidation trial system, 
patentees are burdened by repeated attacks against the same patent 
and a resolution of patent validity is delayed.162  In 2003, seven 
years after its introduction, the post-grant opposition procedure 
was abolished,163 leaving a modified invalidation trial system as 
the sole mechanism for nullifying a Japanese patent filed or issued 
after January 1, 2004.164  The new “Trial for Invalidity,” effective 
January 1, 2004, is largely an integration of the two previous 
procedures of post-grant opposition and invalidation trial.165 
2. Initiation and Conduct of the Trial for Invalidity 
Under the new Trial for Invalidity system, the request for 
invalidation trial can be filed at any time,166 even after the 
expiration of the patent term.167  The identity of the true party in 
 
 158 See id. 
 159 See id. 
 160 See id. 
 161 See id.  The success rate for the challenging party in invalidation trials is about 24%, 
slightly higher than in oppositions, but it has been increasing. See id. 
 162 See id. 
 163 See id. at 1–2. 
 164 See id.  The post-grant opposition system will continue to be available for any patent 
granted on or before December 31, 2003. See Harold C. Wegner, Tokyo Patent 
Enforcement & Invalidation: Implications for American Litigation from Blonder-Tongue 
to Trans-Border Enforcement, 8 n.12, paper presented at the Eleventh Annual Conference 
on International Intellectual Property Law & Policy, Fordham University School of Law, 
April 24 & 25, 2003, New York City. 
 165 See, e.g., Masaki Yoshino, Patent Law Amended, Practical Law Company, at 
http://www.plcinfo.com/scripts/article.asp?Article_ID=35697 (last visited Oct. 25, 2004). 
 166 See Asami, supra note 149, at 3. 
 167 See Japan Patent Law, § 123(2) (1999), an English translation of which is available 
at http://www.jpo.go.jp/shoukaie/patent.htm (last visited Oct. 18, 2004) [hereinafter 
Japan Patent Law]. 
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interest need not be identified.168  The entire procedure is inter 
partes.169  The patentee can file a response to the invalidation 
request, and the response can include narrowing amendments to 
the claims.170  The requester generally will have a second 
opportunity to furnish new evidence, usually in response to 
narrowing amendments by the patentee.171  The trial will proceed, 
generally in the format of an oral hearing,172 before a three-
member panel of the Board of Appeals and Trials,173 which 
reaches a final decision in about fifteen months.174  The members 
of the JPO Board of Appeals and Trials are highly experienced.  
Each member has at least ten years of patent examination 
experience, as well as excellent educational backgrounds.175 
3. Grounds for Invalidation 
Under the new invalidation trial system, challenges to patent 
validity can be based on almost any ground upon which a patent 
may be found invalid.176  As many as sixteen specific grounds have 
been articulated by some practitioners.177  Interestingly, however, a 
 
 168 See Asami, supra note 149, at 2, 4.  The procedure before January 1, 2004 requires 
that only an interested party may seek a Trial for Invalidity. See Wegner, supra note 164, 
at 9 n.13. 
 169 See Wegner, supra note 164, at 8 n.12. 
 170 See Asami, supra note 149, at 5. 
 171 See id. 
 172 See id.; Wegner, supra note 164, at 9. 
 173 The Board of Appeals and Trials, with more than 300 members, handles not only 
Trials for Invalidity and oppositions, but also appeals from rejections of patent 
applications.  In 2001, there were about 300 Trial for Invalidity cases, 3500 oppositions, 
and 20,000 appeals of patent application rejections. See Asami, supra note 149, 2 n.2 and 
accompanying text. 
 174 See id. at 6. 
 175 Most members are graduates of Japan’s top universities and more than 85% have a 
Master’s degree. See id. at 5; Wegner, supra note 164, 9 n.15.  The qualifications of the 
panel members of the Patent Examination Board of the SIPO are similar to those of the 
JPO. See supra Part II. 
 176 See Japan Patent Law, supra note 167, § 123(1). 
 177 See Global IP Group, Japanese Patent Law, IX: Trial for Invalidity, at 
http://www.shinjyu.com/articles/01Japanese_Patent (last visited Oct. 18, 2004), which 
provides: 
A third party who is or may be adversely affected by a patent may demand a 
trial for the invalidation of the patent under the following circumstances: 
(1) new matter was added to the application during prosecution; 
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patent cannot be invalidated on the ground that the applicant 
intentionally withheld relevant prior art during prosecution, even if 
such prior art could conceivably render the invention 
unpatentable.178 
4. Outcomes of the Invalidation Trial and Their Effects 
The decision of the invalidation trial can be to revoke the 
challenged patent, to maintain the patent as granted, or to maintain 
the patent as amended.179  A patent right will be deemed never to 
 
(2) a patent was granted to an applicant that is a resident of a country which 
does not grant reciprocal privileges to Japanese residents; 
(3) the invention is not industrially applicable; 
(4) the invention was publicly known in Japan prior to the filing date of the 
application; 
(5) the invention was publicly worked in Japan prior to the filing date of the 
application; 
(6) the invention was described in a publication distributed in Japan or 
elsewhere prior to the filing date of the patent application; 
(7) the invention could have been easily made, prior to the filing date of the 
application, by a person with ordinary skill in the art to which the invention 
pertains; 
(8) the applicant was not the first one to file a patent application for the 
invention; 
(9) the invention is liable to contravene public order, morality or public health; 
(10) the patent was granted contrary to the provisions of a treaty; 
(11) the specification does not describe the invention in a manner sufficiently 
clear and complete for the invention to be carried out by a person having 
ordinary skill in the art to which the invention pertains; 
(12) the allowed claims are not clear and concise; 
(13) an English language patent application was originally filed, and the 
Japanese language translation of such includes matter not disclosed in the 
English version. 
(14) the patent has been granted on a patent application filed by a person who is 
not the inventor and has not succeeded to the right to obtain a patent for the 
invention concerned; 
(15) when the patentee has become a resident of a country that does not grant 
reciprocal privileges to residents of Japan, or the patent in question no longer 
complies with a treaty; and 
(16) the patentee has been allowed to correct the specification or drawings of 
the patent after grant in a manner which adds new matter. 
 178 See id. (XIV: Prior Art Disclosure Requirement). 
 179 See Mossinghoff & Kuo, supra note 150, at 248; see also supra note 170 and 
accompanying text. 
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have existed if a final and conclusive decision has been made that a 
patent is invalid.180 
5. Appeal 
Either the requester or the patentee may seek review in the 
Tokyo High Court.181  The patentee seeking such an appeal has a 
further opportunity to make narrowing amendments to the 
patent.182  Under the new Trial for Invalidity rules, such 
amendments must be made within ninety days of the Trial Board’s 
decision at the JPO.183  The Tokyo High Court can remand the case 
back to the JPO when the patentee makes such amendments, and 
the JPO will examine both the legitimacy of the patentee’s 
requested amendments and the arguments filed by the requester of 
the invalidation trial in response thereto.184  In a suit against an 
invalidation trial decision, the JPO is not a party to the suit.185  
When appropriate, however, the court can request the JPO to state 
an opinion relating to the interpretation of the law and examination 
guidelines.186  Also, with the court’s permission, the JPO may file 
such an opinion on its own initiative.187  A party not satisfied with 
 
 180 See Japan Patent Law, supra note 167, § 125. 
 181 See Asami, supra note 149, at 6.  There are five kinds of courts in Japan: The 
Supreme Court, High Courts, District Courts,  Family Courts and Summary Courts.  It is 
likely a result of American influence that the power granted to the Supreme Court and 
limitations thereto are somewhat similar to that of the U.S. Supreme Court.  Each of the 
eight High Courts covers its own territorial jurisdiction, like the U.S. Federal Circuit 
courts, but they have original jurisdictions in certain subject matters such as election 
disputes.  The District Courts have original jurisdiction over all cases except those that 
fall within the specific jurisdiction of other courts.  The Family Courts, also directly 
below the High Courts (like the District Courts, to which they are parallel), hear both 
cases involving family conflicts, as well as juvenile delinquency cases.  The Summary 
Courts, which are directly under the District Courts, hears small claims civil cases and 
certain minor criminal cases. See Supreme Court of Japan, An Overview of the Judicial 
System, at http://www.courts.go.jp/english/soshikie_1.html (last visited Oct. 26, 2004). 
 182 See Asami, supra note 149, at 6. 
 183 See id. 
 184 See id. at 6–7. 
 185 See Onda Techno, Amendments to Japanese Patent Law, Statement of Opinion by the 
JPO in a Suit against Trial Decision, at http://www.ondatechno.com/English/topics-
/20040205.html (last visited Oct. 26, 2004). 
 186 See id. 
 187 See id. 
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the decision of the Tokyo High Court may appeal to the Supreme 
Court.188 
6. Statistics of Use 
In 2001, about 110,000 patents were granted in Japan.189 
Against the granted patents, about 4000 oppositions and 283 
invalidation trials were demanded,190 representing about 4% of the 
granted patents.  Of the Board’s decisions in the invalidation trials 
in the same year, 156 were appealed to the Tokyo High Court.191  
In contrast, only 153 infringement suits were filed in District 
Courts in Japan in 2001,192 a very small number compared to the 
more than 1700 cases filed in the United States in the same year.193  
It is too early to see how frequently Japan’s new invalidation trial 
system will be used. 
B. EPO 
The European Patent Convention (“EPC”) went into effect on 
June 1, 1978 with the opening of the European Patent Office 
(EPO) in Munich.194  The EPC provides for an opposition 
procedure for challenging a granted European patent.195 
 
 188 See Shiotsuki, supra note 153, at 87. 
 189 See Japan Patent Attorneys Association, 2003 Amendment to Japan Patent Law, 
§ 2.1: Recent Statistics in Legal Dispute over a Patent Right, at http://www.jpaa.or.jp-
/english/law/2003amendment.html (last visited Oct. 26, 2004). 
 190 See id. 
 191 See id. 
 192 See id. 
 193 See Law.com, Methodology (May 7, 2002), at http://www.law.com/jsp-
/statearchive.jsp?type=Article&oldid=ZZZKAS5FS0D (citing a survey conducted by IP 
Worldwide). 
 194 European Patent Office, European Patent Convention, http://www.european-patent-
office.org/legal/epc/e/ma1.html#CVN (last amended Dec. 10, 1998) [hereinafter EPC].  
In principle, the EPC has nothing to do with the European Community (EC) or European 
Union (EU), because it was created by a treaty between the participating countries 
(Contracting States), rather than by the EC/EU authorities. See John Richards, Guide to 
Patent Protection under the European Patent Convention, 2–5 (unpublished manuscript 
on file with author) [hereinafter Richards, Patent Protection under the EPC].  Thus an 
EU member is not necessarily an EPC member, and vice versa.  For a list of the current 
EPC Contracting States, see EPC, art. 1 n.1. 
 195 See EPC, supra note 194, arts. 99–105. 
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1. Filing of an Opposition 
Through an EPC opposition, any person may obtain the 
limitation or revocation of a wrongly granted European patent.196  
“Any person” means any natural person (such as private 
individuals, self-employed persons, etc.) or any legal person (such 
as corporations).197  But “any person” does not include the 
proprietor of the patent.198  The person filing an opposition need 
not specify any particular interest.199 
The notice of opposition has to be filed with the EPO within 
nine months from the publication of the grant of the patent.200  An 
opposition may be filed even if the European patent has been 
surrendered or has lapsed for all the designated States.201  This is to 
cover situations where patent right disputes arise from the period 
before the surrender or lapse of the patent.202  Also, even if the 
period for filing an opposition has expired, a third party may 
intervene in the opposition proceedings if he proves that 
proceedings for infringement of the patent being opposed have 
been instituted against him, or that he has instituted proceedings 
for a court ruling that he is not infringing the opposed patent in 
response to the patent owner’s request that he cease the alleged 
infringement.203  If the notice of intervention is properly filed 
within specified time limits (e.g., within three months of the date 
 
 196 See European Patent Office, Guidelines for Examination in the EPO, pt. D, ch. I, § 1, 
available at http://www.european-patent-office.org/legal/gui_lines/index.htm (2003) 
[hereinafter EPO Opposition Guidelines].  There are two ways to obtain patent protection 
in Europe, either nationally through patent offices of the individual European countries or 
centrally through the EPO in the form of a European patent.  The EPC, however, does not 
provide a common regime for the enforcement of European patents. See Richards, Patent 
Protection under the EPC, supra note 194, at 2–5. 
 197 See EPC, supra note 194, arts. 58, 99(1). 
 198 EPO Opposition Guidelines, supra note 196, pt. D, ch. I, § 4. 
 199 See id. 
 200 See EPC, supra note 194, art. 99(1).  The notice of opposition can be given to the 
EPO office in Munich, The Hague or Berlin. See EPO Opposition Guidelines, supra note 
196, pt. D, ch. III, § 1. 
 201 See EPC, supra note 194, art. 99(3). 
 202 See EPO Opposition Guidelines, supra note 196, pt. D, ch. III, § 2. 
 203 EPC, supra note 194, art. 105(1). 
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on which the infringement proceedings were instituted), the 
intervention will be treated as an opposition.204 
2. Grounds for Opposition 
The notice of opposition shall contain, inter alia, “a statement 
of the extent to which the European patent is opposed and of the 
grounds on which the opposition is based as well as an indication 
of the facts, evidence and arguments presented in support of these 
grounds.”205 EPC Article 100 sets forth three categories of grounds 
on which the public may oppose a granted European patent:206 (1) 
lack of patentability;207 (2) insufficient disclosure;208 and (3) 
extension of the scope of protection beyond what was contained in 
the application as originally filed.209  For (1) lack of patentability, 
the grounds can be that the claimed invention lacks novelty,210 
inventive step,211 or industrial application,212 or that the claimed 
invention relates to non-patentable subject matter213 or the 
exploitation of which is contrary to public interest or morality.214 
 
 204 See id. arts. 105(1), 105(2). 
 205 Implementing Regulations to the Convention on the Grant of European Patents, Rule 
55(c)—Content of the Notice of Opposition, available at http://www.european-patent-
office.org/legal/epc/e/ma2.html#REG (last amended Dec. 13, 2001) [hereinafter EPC 
Regulations]. 
 206 EPC, supra note 194, art. 100. 
 207 Id. art. 100(a) (“[T]he subject-matter of the European patent is not patentable within 
the terms of Articles 52 to 57.”). 
 208 Id. art. 100(b) (“[T]he European patent does not disclose the invention in a manner 
sufficiently clear and complete for it to be carried out by a person skilled in the art.”). 
 209 Id. art. 100(c) (“[T]he subject-matter of the European patent extends beyond the 
content of the application as filed, or, if the patent was granted on a divisional application 
or on a new application filed in accordance with Article 61, beyond the content of the 
earlier application as filed.”). 
 210 Id. art. 54. 
 211 Id. art. 56. 
 212 Id. art. 57. 
 213 See id. arts. 52, 53(b). 
 214 See id. art. 53(a).  But the publication or exploitation of the invention “shall not be 
deemed to be so contrary merely because it is prohibited by law or regulation in some or 
all of the Contracting States.” Id.  This is different from China, which still holds that 
inventions that violate Chinese laws are not patentable. See supra note 36 and 
accompanying text. 
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3. The Opposition Division 
An Opposition Division is responsible for the examination of 
oppositions against any European patent.215  Regarding the 
composition, tasks and powers of an Opposition Division, the EPC 
provides: 
An Opposition Division shall consist of three technical 
examiners, at least two of whom shall not have taken part 
in the proceedings for grant of the patent to which the 
opposition relates.  An examiner who has taken part in the 
proceedings for the grant of the European patent shall not 
be the Chairman.  Prior to the taking of a final decision on 
the opposition, the Opposition Division may entrust the 
examination of the opposition to one of its members.  Oral 
proceedings shall be before the Opposition Division itself.  
If the Opposition Division considers that the nature of the 
decision so requires, it shall be enlarged by the addition of 
a legally qualified examiner who shall not have taken part 
in the proceedings for grant of the patent.  In the event of 
parity of votes, the vote of the Chairman of the Division 
shall be decisive.216 
If the notice of opposition is deemed admissible after 
evaluation of the formalities,217 “[t]he Opposition Division shall 
communicate the opposition to the proprietor of the patent and 
shall invite him to file observations and, where appropriate, 
amendments to the description, claims and drawings within a 
period to be fixed by the Opposition Division.”218  The 
observations and any amendments filed by the proprietor are then 
communicated by the Opposition Division to all opponents, who, 
when deemed necessary by the Opposition Division, are given an 
opportunity to comment on the proprietor’s submissions.219 
 
 215 EPC, supra note 194, art. 19(1). 
 216 Id. art. 19(2).  The Chairman must be a technically qualified examiner.  See EPO 
Opposition Guidelines, supra note 196, pt. D, ch. II, § 2.3. 
 217 See EPC Regulations, supra note 205, Rule 56 (“Rejection of the notice of 
opposition as inadmissible”). 
 218 Id. Rule 57(1). 
 219 Id. Rule 57(3). 
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4. Conduct of the Opposition 
The proceeding of the substantive examination before the 
Opposition Division is quite flexible.  There is no fixed schedule of 
pleadings and counter-pleadings between the parties, and the time 
limits set by the Opposition Division can be extended for cause.220  
Parties are invited by the Opposition Division as often as necessary 
to file observations on communications from the other party or 
from the Opposition Division.221  Although substantive 
examination of the opposition generally starts with written 
submissions and evidence, oral proceedings will be held if the 
Opposition Division deems it appropriate, or if any party so 
requests.222  During the oral proceedings, the parties are not 
allowed to introduce new facts or evidence, unless the Opposition 
Division concludes that such facts or evidence is critically 
important.223  The oral proceedings are public.224 
5. Outcomes of the Opposition Proceeding and Their Effects 
There are three possible outcomes of an opposition proceeding 
in the EPO: (1) revocation of the European patent;225 (2) rejection 
of the opposition;226 and (3) maintenance of the European patent as 
amended.227  If a European patent has been revoked, the European 
patent application and the resulting patent will be deemed to have 
not had any rights that would have been conferred by a European 
patent application after publication or by a European patent.228  
The outcome of the opposition proceedings is published in the 
 
 220 See M. Trinidad Arriola, Key Features of the European Patent Office (EPO) 
Opposition Procedures,  CASRIP NEWSLETTER (Center for Advanced Study and Res. on 
Intell. Prop, Seattle, WA.), Spring/Summer 1997, at http://www.law.washington.edu-
/casrip/newsletter/newsv4i2eu1.html. See also EPC, supra note 194, art. 101(2). 
 221 See Arriola, supra note 220. 
 222 EPC, supra note 194, art. 116(1). 
 223 See Arriola, supra note 220. 
 224 See EPC, supra note 194, art. 116(4). 
 225 See id. art. 102(1). 
 226 See id. art. 102(2). 
 227 See id. art. 102(3). 
 228 See id. art. 68. 
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European Patent Bulletin as soon as the proceedings are 
concluded.229 
Even though an opposition is filed with respect to only one or 
some of the EPC Contracting States in which that patent has effect 
(“the designated States”),230 the opposition applies to the European 
patent in all the designated States.231  However, the specific effects 
of an opposition may differ among the designated States, because 
the patent may contain different claims or different prior art may 
exist in different designated States.232  Thus the patent may be 
amended differently in different designated States, or may be 
revoked in one or more designated States but not in others.233 
6. Appeal 
Any party to the opposition who is adversely affected by the 
decision of the opposition may appeal.234  The other parties to the 
opposition have the right to be parties to the appeal proceedings.235 
An appeal can be filed even if the European patent has been 
surrendered, or has lapsed for all the designated States.236  But the 
notice of appeal must be filed in writing within two months of the 
notification of the Opposition Division’s decision, and the grounds 
for appeal must be filed in writing within four months of the 
notification of such decision.237 
The appeal is examined by the Board of Appeal.238  During the 
examination process, the Board of Appeal, as often as necessary, 
invites the parties to file observations on communications from 
another party or from the Board of Appeal itself.239  The Board of 
 
 229 See EPO Opposition Guidelines, supra note 196, pt. D, ch. I, § 8. 
 230 Currently there are the twenty-eight Contracting States in the EPC. See EPC, supra 
note 194, art. 1.  An applicant for a European patent should designate in which of the 
Contracting States protection for the invention is desired. See id. art. 79(1). 
 231 See id. art. 99(2). 
 232 See EPO Opposition Guidelines, supra note 196, pt. D, ch. I, § 3. 
 233 Id. 
 234 See EPC, supra note 194, art. 107. 
 235 Id. 
 236 See id. art. 106(2). 
 237 See id. art. 108. 
 238 See id. art. 110(1). 
 239 See id. art. 110(2). 
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Appeal can either make a decision on the appeal, or remand the 
case back to the Opposition Division for further examination based 
on the Board of Appeal’s legal instructions.240  When important 
issues of law are involved, or in order to ensure uniform 
application of law, the Board of Appeal can refer questions of law 
to the Enlarged Board of Appeal.241  The entire opposition 
procedure, including appeals, may take up to five years or more.242 
7. Statistics of Use 
The drafters of the EPC opposition procedure generally 
expected, based on prior experience with oppositions at national 
patent offices, that about 20–25% of the European patents granted 
would be opposed.243  Contrary to these forecasts, however, recent 
studies show that oppositions have been filed against just 6–8% of 
European patents.244  Data from recent years show that about 35% 
of the patents opposed are revoked, about 30% are maintained in 
an amended form, and about 35% of the oppositions are 
rejected.245 
C. United States 
1. Brief History of the Reexamination System 
Currently, in the United States, a party can challenge the 
validity of a U.S. patent in a District Court if the party has been 
 
 240 See id. art. 111. 
 241 See id. art. 112(1)(a).  “For giving decisions or opinions, the Enlarged Board of 
Appeal shall consist of five legally qualified members and two technically qualified 
members.  One of the legally qualified members shall be the Chairman.” Id. art. 22(2). 
 242 See Arriola, supra note 220. 
 243 See id. 
 244 See id. (“At first blush, the number of oppositions filed may seem surprisingly low 
when compared to the 25% posted by the German Patent Office in earlier years.  
Although this result may be attributed to disfavor for or dissatisfaction with the 
opposition procedure, other factors may account for this low turnout.  First, trivial and 
insignificant applications are usually not filed at the EPO but usually remain with the 
national offices; and second, the EPO boasts a superior search procedure compared to 
those of the national offices.”). 
 245 See id. 
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sued for infringement, or in the USPTO through reexamination 
procedures.246 
Patent reexamination, i.e., a second examination of an issued 
patent, was established in 1980 by Congress,247 which was 
concerned with the quality of patents and was trying to restore 
confidence in the patent system.248  Congress also had other 
considerations in creating this administrative process of 
reexamination: to provide a cheaper and quicker way to resolve a 
patent validity dispute than through District Courts,249 and to rely 
on the expertise of the USPTO in evaluating whether a patent 
should have been granted.250  We now look at the U.S. 
reexamination systems in more detail and see whether the 
objectives of Congress have been achieved. 
2. Ex Parte Reexamination 
As introduced, the reexamination procedure is ex parte in 
nature.251  Under the U.S. patent law, “[a]ny person at any time 
may cite to the [Patent] Office in writing prior art consisting of 
patents or printed publications which that person believes to have a 
bearing on the patentability of any claim of a particular patent.”252  
There is no requirement that the person submitting such prior art 
request a reexamination.253  If the person explains in writing the 
pertinence and manner of applying the prior art to at least one 
claim of the patent, the prior art and the explanation become part 
of the official file of the patent.254  The identity of the person 
submitting the prior art and the explanation can be kept 
confidential at such person’s request.255 
 
 246 See 35 U.S.C. §§ 282, 302 (2003). 
 247 Id. §§ 302–307. 
 248 See John Whealan, Validity Challenges in Re-examination Proceedings, 7 CASRIP 
PUBLICATION SERIES, RECONCILING INTERNATIONAL INTELLECTUAL PROPERTY 42, 
http://www.law.washington.edu/casrip/Symposium/Number7/2A-Whealan.pdf (July 
2002).  The Federal Circuit was established in the same year. Id. 
 249 Id. 
 250 Id. 
 251 35 U.S.C. §§ 302, 307. 
 252 Id. § 301. 
 253 See Whealan, supra note 248, at 42–43. 
 254 35 U.S.C. § 301. 
 255 Id. 
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Any person, including the patent owner, at any time, may file 
in writing a request for (ex parte) reexamination of any claim of a 
patent on the basis of any prior art cited as described in the last 
paragraph.256  The request must set forth the pertinence and 
manner of applying the cited prior art to every claim for which 
reexamination is requested.257 
The Patent Office, within three months after the filing of a 
request for reexamination, will determine whether the request 
raises a substantial new question of patentability affecting any 
claim of the patent concerned.258  Also, the Patent Office may, on 
its own initiative, determine whether a substantial new question of 
patentability is raised by patents and publications discovered by 
the Patent Office or cited by any person.259  Even if a patent or 
printed publication was previously considered by the examiner 
during the prosecution of the patent, it could still raise a substantial 
new question of patentability.260  If the Patent Office determines 
that no new substantial question of patentability has been raised by 
the cited patent or printed publication, such decision is final and 
may not be appealed.261 
a) Grounds for Requesting Reexamination 
Although the reexamination will be conducted according to the 
same standards of patentability as for initial examination, the 
issues that can be considered during a reexamination are much 
more limited than during the initial examination.  They are limited 
to “substantial new questions of patentability” that are raised by 
the cited prior art and that have not been previously seen by the 
examiner.262  And, since the prior art cited for reexamination 
 
 256 Id. § 302. 
 257 Id. § 302. 
 258 Id. § 303(a). 
 259 Id.  Such Director-ordered reexaminations are quite rare and are often to address a 
public outcry against certain patents.  Of the 154 reexaminations ordered by the Director 
since 1981, 87% resulted in the patent being revoked or narrowed in scope. See  Intell. 
Prop. L. Bull., Pfizer Faces Setbacks in Patent Battle over Viagra (Feb. 19, 2004), at 
http://www.iplawbulletin.com/cgi-bin/absolutenm/anmviewer.asp?a=986. 
 260 35 U.S.C. § 303(a). 
 261 Id. § 303(c). 
 262 See Whealan, supra note 248, at 43. 
SUN 1/25/2005  6:16 PM 
2004] POST-GRANT PATENT INVALIDATION 311 
purposes can only be patents or printed publications, these issues 
must arise from the submitted patents or printed publications.263  
The cited prior art can be art that the examiner did not consider 
during the initial examination, or art that the examiner considered 
previously but not in the same light.264  Typically, the patentability 
issues considered during reexamination are limited to 35 U.S.C. 
§ 102 (novelty) and § 103 (obviousness).265  Thus, at least 
theoretically, if what is claimed in the challenged patent is 
unpatentable subject matter under 35 U.S.C. § 101, such as a 
perpetual motion machine, the patent cannot be reexamined and 
invalidated on that basis.266 
b) Participation by Parties 
If the Patent Office allows the request for reexamination, and if 
the requesting party is not the owner of the challenged patent, the 
Patent Office will send a copy of the reexamination request to the 
patent owner.267  The patent owner has the option to submit 
statements, including amendments or new claims, for consideration 
during reexamination.268  Such amendments or new claims must 
not enlarge the scope of the patent.269  And if the patent owner 
does submit such statements, the requester has an opportunity to 
respond to the patent owner’s statements.270  But that is all the 
requester can do in an ex parte reexamination—he cannot further 
 
 263 35 U.S.C. § 301. 
 264 See supra note 260 and accompanying text. 
 265 See Whealan, supra note 248, at 43.  Thus, if the Chinese Viagra patent was 
invalidated solely based on enablement/written description issues (and no other grounds 
for invalidation were sustainable), under current U.S. law the same patent in the U.S. 
probably would not be invalidated. 
 266 See id.  If the new or amended claims proposed by the patent owner during 
reexamination are being examined for the first time, the examiner can consider §§ 101 
and 112, and any other issues that relate to patentability. See id. at 44.  In addition, the 
challenger will still have the option of going to court. See id. at 43.  This illustrates a 
serious limitation of the current U.S. reexamination procedure, given that the 
reexamination system was created to provide a cheaper and quicker resolution of a 
validity dispute than through District Courts. See id. at 42. 
 267 35 U.S.C. § 302. 
 268 Id. § 304. 
 269 See id. § 305. 
 270 Id. § 304. 
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participate.271  In fact, a requester rarely gets this limited chance to 
participate.  Few patent owners would submit statements after 
receiving the reexamination order, because doing so would permit 
the requester a second chance to attack the patent.272 
c) Who Does the Reexamination? 
Who at the USPTO conducts the reexamination?  Is the task 
entrusted to a panel of expert examiners, like those in Japan, the 
EPO, or China?  Actually none of the above.  The USPTO treats 
reexamination truly as examination for a second time, and 
conducts the reexamination in the same fashion as the patent 
application was examined in the first instance.273  But it is said that 
the Patent Office does try to do the reexamination faster and more 
carefully than an initial application.274  Historically, the examiner 
chosen for the reexamination had generally been the examiner who 
examined the initial application that issued into the challenged 
patent.275  Recently, the USPTO adopted a general policy to assign 
the reexamination to an examiner different from the examiner(s) 
who examined the initial application.276  Another recent change in 
the reexamination practice is that, to enhance the quality of ex 
parte reexamination, a “patentability review conference” will be 
convened in each ex parte reexamination proceeding (1) just 
before issuing a final rejection of claims, and (2) just before 
 
 271 See Whealan, supra note 248, at 43. 
 272 See id. 
 273 See 35 U.S.C. § 305 (“[R]eexamination will be conducted according to the 
procedures established for initial examination.”); see also Whealan, supra note 248, at 
43. 
 274 See 35 U.S.C. § 305 (“All reexamination proceedings under this section . . . will be 
conducted with special dispatch within the Office.”); see also Whealan, supra note 248, 
at 43. 
 275 USPTO, Change in Policy of Examiner Assignment in Ex Parte Reexamiation 
Proceedings and Establishment of Patentability Review Conferences in Ex Parte 
Reexamination Proceedings, 1237 OG 138 (Aug. 29, 2000), http://www.uspto.gov-
/web/offices/com/sol/og/2000/week35/patreex.htm. 
 276 Id.  An exception to this general policy will apply if, for example, the original 
examiner is the only examiner with adequate knowledge of the relevant technology. Id. 
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issuing a Notice of Intent to Issue Reexamination Certificate to 
confirm or allow claims.277 
3. Inter Partes Reexamination 
In 1999, the American Inventors Protection Act (AIPA)278 
introduced “inter partes reexamination” into the U.S. 
reexamination system.279  The biggest difference between ex parte 
reexamination and inter partes reexamination is that the latter 
allows the requestor to participate in the process and to respond to 
everything the patent owner says.280  Also, unlike ex parte 
reexamination, the request for inter partes reexamination must 
provide the identity of the real party in interest.281 
Several aspects of the inter partes reexamination are similar to 
those of the ex parte reexamination: any third party can, at any 
time, file a request for inter partes reexamination of a patent;282 the 
prior art that can be relied upon for inter partes reexamination is 
the same as for ex parte reexamination;283 the request must be in 
writing and must set forth the pertinence and manner of applying 
the cited prior art to every claim for which reexamination is 
requested;284 the Patent Office will determine whether the request 
raises a substantial new question of patentability affecting any 
claim of the patent;285 the reexamination will be conducted 
 
 277 Id.  The patentability review conference will consist of three members, one of whom 
will be the examiner in charge of the reexamination.  The other two members will be 
examiners, such as Primary Examiners, who are knowledgeable in the technology of the 
invention and/or who are experienced in reexamination practice. Id.  This seems to be in 
part an effort by the USPTO to address the perception that the ex parte reexamination 
proceeding is unduly favorable to the patentee. See id. 
 278 The American Inventors Protection Act of 1999, Pub. L. No. 106-113, 113 Stat. 
1537-544 (codified as amended in scattered sections of 35 U.S.C.), available at 
http://www.uspto.gov/web/offices/dcom/olia/aipa/index.htm [hereinafter AIPA].  The 
AIPA was later amended. Intellectual Property and High Technology Technical 
Amendments Act of 2002, Pub. L. No. 107-273, 116 Stat. 1758. 
 279 The provisions of the AIPA regarding inter partes reexamination are codified in 35 
U.S.C. §§ 311–318 (2003).  
 280 See Whealan, supra note 248, at 47; see also 35 U.S.C. § 314(b). 
 281 35 U.S.C. § 311(b)(1). 
 282 See id. § 311(a). 
 283 See id. 
 284 Id. § 311(b)(1)–(2). 
 285 Id. § 312(a). 
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according to the procedures established for initial examination;286 
the patent owner is permitted to propose non-broadening 
amendments and/or new claims;287 and all the proceedings are 
conducted with special dispatch.288  Also, neither the requester nor 
the patent owner can appeal the Patent Office’s determination of 
whether the request raises a substantial new question of 
patentability affecting any claim of the patent.289 
Regarding the back-and-forth nature of the inter partes 
process, any documents filed by either the patent owner or the 
requester, except the request for reexamination itself, are served on 
the other party.290  In addition, the requester is entitled to receive a 
copy of any communication the Patent Office sends to the patent 
owner concerning the reexamination.291  Each time the patent 
owner files a response to a Patent Office Action on the merits, the 
third-party requester will be given one opportunity to file written 
comments addressing issues raised by the Office Action or the 
patent owner’s response thereto.292 
4. Appeal 
The patent owner in either an ex parte or an inter partes 
reexamination can appeal from any decision adverse to the 
patentability of the patent reexamined.293  Such an appeal should 
be filed to the Board of Patent Appeals and Interferences 
(BPAI).294  If not satisfied with the final decision of the BPAI, the 
patent owner can then appeal to the United States Court of Appeals 
for the Federal Circuit (CAFC).295 
 
 286 Id. § 314(a). 
 287 See id. § 314(a). 
 288 Id. § 314(c). 
 289 Id. § 312(c).  Whereas in an ex parte reexamination proceeding, the statute expressly 
prohibits only the requester from appealing a determination that no new substantial 
question of patentability has been raised. See supra note 261 and accompanying text. 
 290 See id. § 314(b)(1) (“With the exception of the inter partes reexamination request, 
any document filed by either the patent owner or the third-party requester shall be served 
on the other party.”). 
 291 See id. 
 292 See § id. 314(b)(2). 
 293 See id. §§ 306, 315(a)(1). 
 294 See id. § 134(b). 
 295 See id. § 141. 
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Although the requester in an ex parte reexamination does not 
have the right to appeal from a decision of the ex parte 
reexamination,296 a third-party requester in an inter partes 
proceeding may appeal to the BPAI from a final decision favorable 
to the patentability of the challenged patent or part thereof.297  And 
if the third-party requester is not satisfied with the final decision of 
the BPAI, it can then appeal to the CAFC.298 
Both the patent owner and the third-party requester are entitled 
to be a party to any appeal taken by the other party.299  If, in an 
inter partes reexamination, any claim of the challenged patent is 
found valid after exhaustion of appeal, the third-party requester 
cannot at a later time challenge the validity of such claim in a civil 
trial (such as in a District Court) based on any ground that the 
third-party requester raised or could have raised during the inter 
partes reexamination proceedings.300  This estoppel does not apply, 
however, if the assertion of invalidity in the civil trial is based on 
newly discovered prior art unavailable to the third-party requester 
or the USPTO at the time of the inter partes reexamination.301  
Nevertheless, this estoppel is an important concern for third-party 
requesters.302 
 
 296 The requester is not considered a party to the ex parte reexamination process, and the 
statutory provision regarding appeal from a decision in an ex parte reexamination only 
provides the patent owner a right to appeal from adverse decisions. See id. § 306. 
 297 Id. § 134(c). 
 298 Id. § 141.  The AIPA as originally enacted specifically precluded the third-party 
requester of the inter partes reexamination from appealing a decision of the BPAI to the 
CAFC. See id. § 134(c), amended by AIPA, 113 Stat. 1501A-571.  The 2002 amendment 
to the AIPA changed this. See Changes to Implement the 2002 Inter Partes 
Reexamination and Other Technical Amendments to the Patent Statute, 68 Fed. Reg. 
70996 (Dec. 30, 2003), available at http://www.uspto.gov/web/offices/com/sol-
/og/2004/week03/patchng.htm (last visited Oct. 29, 2004). 
 299 See 35 U.S.C. §§ 315(a)(2), 515(b)(2).  The AIPA as originally enacted did not 
permit the third party requester to participate in an appeal taken by the patent owner to 
the CAFC.  The 2002 amendment to AIPA provided this right to the third-party requester. 
See Changes to Implement the 2002 Inter Partes Reexamination and Other Technical 
Amendments to the Patent Statute, 68 Fed. Reg. 70996 (Dec. 30, 2003). 
 300 See 35 U.S.C. § 315(c). 
 301 See id. 
 302 See Whealan, supra note 248, at 47. 
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5. Outcomes of the Reexamination and Their Effects 
In both an ex parte and an inter partes reexamination, when the 
time for appeal has expired or any appeal proceeding has 
terminated, the Patent Office will issue and publish a certificate 
indicating the status of the reexamined patent.303  Any claim of the 
patent, including a claim added or amended during reexamination, 
could be found either patentable, unpatentable, or patentable as 
amended.304  The new or amended claims in a reexamined patent 
are enforceable subject to certain third-party intervening rights.305 
6. Statistics of Use 
It generally takes one to two years to complete an ex parte 
reexamination, even though reexamination is given top priority in 
the USPTO.306  Interestingly, third parties requested about 55%, 
and patent owners about 43%, of the reexaminations.307 
A 2001 report revealed that, during the first twenty years after 
the inception of ex parte reexamination, there had been on average 
about 300 reexaminations per year, which was about 0.2% of the 
average 150,000 patents issued each year.308  In recent years, the 
fraction of issued patents that have been reexamined is even 
smaller than 0.2%.309  There had been a decrease in the number of 
reexamination requests since the 1996 CAFC decision in In re 
Recreative Technologies Corp.,310 which held that the challenger 
of a patent cannot in reexamination rely on art already cited during 
initial prosecution of the patent application, even though the art 
raises new questions during reexamination.311  This rule has since 
 
 303 See 35 U.S.C. §§ 307(a), 316(a). 
 304 See id. §§ 307(a), 316(a). 
 305 See id. §§ 252, 307(b), 316(b). 
 306 See Whealan, supra note 248, at 44. 
 307 See id. 
 308 See id. 
 309 See USPTO, Performance and Accountability Report Fiscal Year 2003, at 
http://www.uspto.gov/web/offices/com/annual/2003/060401_table1.html (last modified 
Feb. 13, 2004). 
 310 83 F.3d 1394 (Fed. Cir. 1996); see also Whealan, supra note 248, at 44. 
 311 See Whealan, supra note 248, at 45. 
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been preempted by the November 2002 amendments of the AIPA, 
as embodied in 35 U.S.C. § 303(a).312 
Of the reexamined patents at the USPTO, about 26% were 
maintained unchanged, about 10% are revoked in full, and about 
64% are maintained after some amendments.313  The requests for 
reexamination seem to spread evenly across different technological 
areas.314 
The inter partes reexamination has been scarcely used since its 
inception in November 1999.  From that time until November 
2002, it has been used only four times.315  One proposed 
explanation for this is that there had not been many patents eligible 
for inter partes reexamination—it takes about two years for a 
patent to issue and inter partes reexamination applies only to 
patents filed and issued after November 29, 1999.316  Now that 
more time has passed, are we seeing a different picture? 
During the first twelve weeks of 2004, the USPTO Official 
Gazette published seventy-seven requests for ex parte 
reexamination, but only six requests for inter partes 
reexamination.317  Interestingly, twenty-two of the seventy-seven 
ex parte reexamination requests—nearly 30%—could have been 
filed as inter partes reexamination, because the patents concerned 
were filed after November 29, 1999.318  The rarity of inter partes 
reexamination, therefore, may not be explained by the fact that 
only patents filed and issued after November 29, 1999 are eligible 
for inter partes reexamination.  If the inter partes reexamination 
procedure does not encourage third parties to file requests for 
reexamination (relative to the ex parte procedure), then the 
 
 312 Pub. L. No. 107-273, § 13105, 116 Stat. 1900 (codified as amended by 35 U.S.C. § 
303(a) (2002)); see also supra notes 260, 264 and accompanying text. 
 313 See Whealan, supra note 248, at 45. 
 314 See id. 
 315 See FTC Report, supra note 17, ch. 5, at 16. 
 316 See Whealan, supra note 248, at 47. 
 317 See USPTO, Official Gazette Notices for 2004, http://www.uspto.gov/web/offices-
/com/sol/og/2004/2004.htm (last visited Oct. 29, 2004). 
 318 See id. 
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introduction of inter partes reexamination will not result in an 
increase in the overall usage of the reexamination procedure.319 
IV. CHINA’S POST-GRANT INVALIDATION SYSTEM IN COMPARISON 
 WITH THOSE OF THE TRILATERAL OFFICES 
In today’s patent world, many patents are of poor quality and 
are invalid.320  In the United States, for example, great concern has 
been raised about the number of questionable patents issued.321 It 
is reported that the USPTO approves as many as 97% of the 
applications placed before it.322  Patents for “business methods” 
implemented in software are frequently of very poor quality, 
because patents in this area are routinely issued overlooking 
clearly anticipating prior art.323  Biotech firms, while regarding 
patents as the basis for their industry, are concerned that overbroad 
patents may discourage further innovation in biotechnology.324  
Budgetary limitations, an exploding filing rate, and the expanding 
range of patentable subject matter are cited as reasons for the 
decline in the quality of U.S. patents.325  This problem, however, is 
not unique to the U.S.; the JPO and EPO, for example, are facing 
equally challenging circumstances.326  The fact that about two-
thirds of the opposed patents in the EPO were either revoked in full 
or amended underscores the concern about patent quality.327 
 
 319 An estimation based on the data from the Official Gazette Notices for 2004 suggests 
that there will be over 300 requests for reexamination in 2004, a number not too far from 
the recent average of about 250 requests per year. See id. 
 320 See Scott R. Boalick, Patent Quality and the Dedication Rule, 11 J. INTELL. PROP. L. 
215, 240 (2004). 
 321 See FTC Report, supra note 17, Executive Summary, at 5. 
 322 See John R. Thomas, The Responsibilities of the Rulemaker: Comparative 
Approaches to Patent Administration Reform, 17 BERKELEY TECH. L.J. 727, 728 (2003) 
(citations omitted). 
 323 See Robert P. Merges, As Many as Six Impossible Patents before Breakfast: Property 
Rights for Business Concepts and Patent System Reform, 14 BERKELEY TECH. L.J. 577, 
589 (1999). 
 324 See FTC Report, supra note 17, Executive Summary, at 5 n.16. 
 325 See Thomas, supra note 322, at 728. 
 326 See id. at 728–29. 
 327 See supra Part III.B.  The situation in the United States is similar: only 26% of the 
reexamined patents were maintained unchanged. See supra note 313 and accompanying 
text. 
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The poor quality of patents makes a functional post-grant 
invalidation procedure extremely important.  The examination of a 
patent application is essentially an ex parte process in the Patent 
Offices, involving only the applicant and the Patent Office.328  It is 
unrealistic to expect that the examiner will always have all the 
relevant information or knowledge for a proper examination of the 
patent application.329  Third party competitors in the same field as 
the applicant, however, may have the best information and 
expertise, as well as the incentive, to assist in the evaluation of a 
patent application.330  Thus, third party participation in the 
patenting process will help improve patent quality.  However, to 
avoid delays in the grant of patents and to prevent harassment of 
patent applicants, the procedure for challenging a patent should be 
after the patent issues.331 
The purpose of a post-grant patent invalidation system is to 
provide an efficient, cost-effective, and reliable mechanism for 
third parties to challenge a granted patent, thereby improving the 
quality of patents.  To achieve this goal, an invalidation system 
should (i) allow challenges to a patent right to be based on any 
issues concerning patentability,332 (ii) allow full participation of 
the third-party challenger, (iii) employ a highly-qualified panel for 
reexamination, and (iv) provide a valid decision in a timely 
manner.  Obviously, balancing would be needed among some of 
these aspects, such as between time limits and the extent to which 
the parties involved are allowed to fully present their arguments 
and evidence. 
Against the backdrop of such a desired system, how does 
China’s invalidation system, or that of the USPTO, EPO or JPO, 
measure up?  In Table 1, several key aspects of China’s current 
patent invalidation system are compared with those of the trilateral 
 
 328 See FTC Report, supra note 17, Executive Summary, at 9. 
 329 See id. 
 330 See FTC Report, supra note 17, Executive Summary, at 8. 
 331 See id.  Consistent with this principle, both China and Japan have abolished their pre-
grant revocation procedures in the 1990s. See supra Parts II, III.A. 
 332 The position of the U.S. Federal Trade Commission is that “[a]t a minimum, patent 
challengers should be able to raise issues of novelty, nonobviousness, written description, 
enablement, and utility.” See FTC Report, supra note 17, Executive Summary, n.26. 
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offices.333  A more in-depth discussion of the practices in the four 
Patent Offices is presented below.  This analysis focuses on 
grounds for requesting invalidation, participation by third-party 
requester, expertise of the reexamination panel, efficiency, and 
frequency of usage. 
A. Grounds for Challenging a Patent 
In China, challenges to the validity of a patent may be based on 
any grounds concerning patentability.334  This is commensurate 
with, if not broader than, the scope of allowable grounds in the 
JPO and the EPO, but is clearly much broader than the limited 
grounds permissible in the United States (i.e., novelty and 
obviousness).335  Moreover, similar to the JPO and EPO practice, 
in SIPO prior art disclosure of the invention could be “by any 
way,”336 in contrast to the U.S. requirement that only patents or 
printed publication can be prior art for post-grant invalidation 
purposes.337 
With respect to novelty under Chinese Patent Law,338 
“disclosure” includes disclosure by publication and non-
publication disclosure.339  Publication disclosure refers to 
disclosure in the form of printed or typed paper documents, film, 
tape, CD-ROM, photograph, etc.340  Non-publication disclosure 
refers to disclosure by various forms other than publication, such 
 
 333 See supra Parts II–III. 
 334 See supra Part II.B. 
 335 See Japan Patent Law, supra note 167, § 123.1; EPC, supra note 194, art. 100; 35 
U.S.C. § 102 (2003). 
 336 See EPC, supra note 194, art. 54(2) (“The state of the art shall be held to comprise 
everything made available to the public by means of a written or oral description, by use, 
or in any other way, before the date of filing of the European patent application.”) 
(emphasis added); see also supra Part III.A–B. 
 337 35 U.S.C. § 301 (2003). 
 338 See Chinese Patent Law, supra note 27, art. 22.2 (“Novelty means that, before the 
date of filing, no identical invention or utility model has been publicly disclosed in 
publications in the country or abroad or has been publicly used or made known to the 
public by any other means in the country . . . .”) (emphasis added). 
 339 See Guidelines, supra note 42, pt. IV, ch. 1, § 12; pt. II, ch. 3, § 2.1.3 (“Methods of 
Disclosure: The methods of disclosure include disclosure by publications, disclosure by 
use and disclosure by other methods.”). 
 340 See id. pt. II, ch. 3, § 2.1.3.1 (“Disclosure by Publication”). 
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as use disclosure,341 oral disclosure,342 and disclosure by non-
publication carrier.343   
To improve patent quality, such a broad definition of disclosure 
is critical.  In performing a substantive examination of a patent 
application, it is far more difficult for the examiner to be aware of 
technology disclosed by use or known to the public through 
methods other than publication or patents.  The prior art before the 
examiner mainly refers to technology disclosed in publications or 
patents.344  Thus, allowing the third party challenger to attack the 
validity of a patent based on issues of patentability arising from 
non-publication art is an important feature of an effective post-
grant invalidation procedure.  Of course, a third-party requester 
should be required to make a suitable threshold showing of 
material issues regarding patentability.345 
B. Participation by Third-Party Requester 
Given the value a third-party requester may add to the 
patenting process, a post-grant invalidation system should allow 
ample opportunity for the third-party requester to participate in the 
reexamination process.  In the SIPO, as well as in the EPO and the 
JPO, the invalidation proceedings are inter partes in nature, and 
the third-party requester is given ample opportunity for 
participation, such as through oral proceedings.346  “The EPO has 
long recognized the inadequacies in simply assigning to third 
parties the role of informant or amicus curiae and then leaving it to 
the Patent Office to use the [cited prior art] material as it sees fit.  
Rather, the European Patent Convention (EPC) grants full party 
status to such participants, thus giving them some control on the 
way the material they provide is handled.”347  In the JPO, the 
invalidation proceeding is literally called a “trial,”348 in effect 
 
 341 See id. pt. IV, ch. 1, § 12.2.5 (“Use Disclosure”). 
 342 See id. pt. IV, ch. 1, § 12.2.6 (“Oral Disclosure”). 
 343 See id. pt. IV, ch. 1, § 12.2.7 (“Disclosure by Non-publication Carrier”). 
 344 See id. pt. II, ch. 3, § 2.3. 
 345 See FTC Report, supra note 17, Executive Summary, at 8. 
 346 See supra Parts II–III. 
 347 See Arriola, supra note 220. 
 348 See generally Japan Patent Law, supra note 167, ch. VI, § 123 (referring to 
invalidation proceedings as “trials”). 
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granting the requester full-party status.349  A requester enjoys a 
similar status in an invalidation proceeding in the SIPO.350 
In the USPTO, patent reexamination can be either an ex parte 
or an inter partes procedure.351  In an ex parte reexamination, 
third-party participation is extremely limited.  Besides the filing of 
a reexamination request, a third-party requester’s only other 
opportunity for participation is to respond to the patent owner’s 
statements in response to the reexamination request.352  In reality, 
the third party rarely gets even this limited opportunity for 
participation because patent owners typically do not submit 
statements in response to the reexamination request.353  In response 
to this widely criticized limitation of ex parte reexamination, inter 
partes reexamination was introduced by the AIPA in 1999.354  A 
third-party requester in an inter partes reexamination can 
participate in the reexamination and respond to everything the 
patent owner says by filing written comments.355 
All the post-grant invalidation procedures of China, the EPO 
and Japan allow oral proceedings involving both the requester and 
the patent owner.356  In China, as in the JPO and the EPO, oral 
proceedings are ordered either at the request of the parties, or 
based upon the need of the case as determined by the 
Reexamination Board.357  Also, the oral proceedings are held 
publicly.358  In the USPTO, however, the reexamination is treated 
as another patent application examination,359 and would therefore 
be ex parte in nature (except that in an inter partes reexamination, 
the third-party requester may participate through filing written 
 
 349 See supra Part III.A. 
 350 See supra Part II.D. 
 351 See supra Part III.C. 
 352 See supra notes 270–71 and accompanying text. 
 353 See supra note 272 and accompanying text. 
 354 See supra note 279 and accompanying text. 
 355 See supra notes 280, 290, 292 and accompanying text. 
 356 See supra Parts II–III. 
 357 See supra notes 109 (China), 172 (JPO), 216 (EPO) and accompanying text. 
 358 See supra notes 96, 111.  For the EPO, see supra note 224.  In the JPO, an oral 
proceeding is generally the format of the invalidation trial. See supra note 172 and 
accompanying text. 
 359 See supra note 273 and accompanying text. 
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submissions360).  Hence, even if there is an interview, it would not 
be open to the public, and the third-party requester would not be 
allowed to participate. 
C. Expertise of the Reexamination Panel 
Just as the expertise of the patent examiner affects the quality 
of the initial examination of a patent application, the expertise of 
the reexamination panel in a patent invalidation case affects the 
quality of the reexamination.  The quality of reexamination in turn 
affects the usage of the invalidation system.  Typically, only  
patents that are economically important are challenged.  Because 
of the economic consequences at stake for both the patentee and 
the third party requester, it makes sense to entrust the role of 
reexamining the challenged patents to highly-experienced 
examiners in order to ensure a reliable determination of the validity 
of the challenged patents. 
The composition of China’s reexamination panel is similar to 
those of the EPO and the JPO.  China’s Patent Reexamination 
Board consists of experienced technical and legal experts of the 
SIPO.361  To further ensure the quality of the reexamination, cases 
involving great economic interests and/or important legal issues 
are examined by a three- to five-member panel.362  An examiner 
who was involved in the initial examination of the application 
leading to the challenged patent cannot serve on the reexamination 
panel.363  Similar collegiate panels are used in the EPO (typically a 
three-member panel of technical examiners, which can be enlarged 
by the addition of a legally qualified examiner)364 and the JPO (a 
three-member panel of examiners with at least ten years of patent 
examination experience).365  Also, to ensure the quality and 
fairness of the reexamination (opposition), the EPC requires that 
 
 360 See supra notes 290–92 and accompanying text. 
 361 See supra note 84 and accompanying text. 
 362 See supra notes 85–89 and accompanying text.  Simple cases, typically not involving 
invention patents, can be examined by a sole examiner. See supra note 85 and 
accompanying text. 
 363 See supra note 90 and accompanying text. 
 364 See supra note 216 and accompanying text. 
 365 See supra note 175 and accompanying text. 
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the Chairman, the optional legal examiner, and at least two of the 
three technical examiners of the Opposition Division must not 
have taken part in the proceedings for grant of the patent.366  In the 
JPO, the invalidation trial is handled by the Board of Appeals and 
Trials, instead of by the examiner who initially approved the 
patent.367 
In contrast, again, the USPTO adopts a different approach: a 
single examiner conducts the reexamination instead of a panel of 
examiners368 (although, in an ex parte reexamination, a 
“patentability review conference” just before issuing a final 
decision has been recently introduced369).  Other than familiarity 
with the claimed subject matter of the patent, there is no special 
requirement regarding the qualifications of the single examiner 
undertaking the reexamination.  A recent policy, however, does 
require, with exceptions, that the examiner not be the same 
individual who originally allowed the patent application.370  While 
the examiner chosen for the reexamination is supposed to perform 
the reexamination more carefully than he or she examines an initial 
application,371  there still exists a concern that reexamination 
unduly favors the patentee.372 
D. Efficiency/Timeliness 
One of the problems with China’s post-grant invalidation 
system is that it takes up to two years for the Reexamination Board 
to issue a decision.373  In China, reevaluation of the validity of a 
granted patent is the sole province of the SIPO Patent 
Reexamination Board.374  The Chinese Patent Law does not 
provide a mechanism to accelerate the invalidation proceedings 
when litigation is pending in a People’s Court.375  Although the 
 
 366 See supra note 216 and accompanying text. 
 367 See supra note 173 and accompanying text. 
 368 See supra note 273 and accompanying text. 
 369 See supra note 277 and accompanying text. 
 370 See supra note 276 and accompanying text. 
 371 See supra note 274 and accompanying text. 
 372 See FTC Report, supra note 17, Executive Summary, at 16. 
 373 See East IP Group, supra note 58. 
 374 See supra note 120 and accompanying text. 
 375 See id. 
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People’s Courts have discretion in whether to stay the litigation 
when an invalidation proceeding is pending in the SIPO, such a 
stay is not common in cases involving invention patents.376  A 
patent found infringed by a People’s Court may be later declared 
invalid by the SIPO Patent Reexamination Board and the SIPO’s 
invalidation decision will not have retroactive effect.377  Thus, the 
Chinese post-grant invalidation system can be improved by 
providing mechanisms to speed up the invalidation process and to 
stay a litigation in court once an invalidation request is made in 
SIPO.378  Corresponding rules can also be enacted to deter undue 
delay and harassment via invalidation requests. 
The average time the USPTO takes to grant a patent is about 
two years.379  Although reexamination is given top priority in the 
USPTO, it generally takes one to two years to complete an ex parte 
reexamination.380 One can expect that an inter partes 
reexamination would probably take longer than an ex parte 
reexamination due to the participation of the third-party requester.  
The duration of an invalidity trial in the JPO does not differ 
significantly from that of the SIPO or the USPTO.  The JPO’s goal 
is to conclude invalidation trials within fifteen months.381 
The EPO, however, takes longer to conclude an opposition.  It 
is estimated that the entire opposition process, including appeals, 
may take up to five years or more.382  The delay is largely because 
 
 376 See supra note 124 and accompanying text.  It is likely that invalidation requests 
involving invention patents are resolved more quickly by the Patent Reexamination 
Board because such patents (but not utility model or design patents) have been 
substantively examined before grant.  Thus, delays by an accused infringer of an 
invention patent, through requesting an invalidation proceeding, are rarer than in cases 
involving infringement of utility model or design patents. See Louis S. Sorell, A 
Comparative Analysis of Selected Aspects of Patent Law in China and the United States, 
11 PAC. RIM L. & POL’Y J. 319, 334 (2003). 
 377 See supra notes 117, 121 and accompanying text. 
 378 An example of such a stay of litigation in the U.S.: a federal judge in the District 
Court for the District of Delaware has put on hold the lawsuit filed by Pfizer against Eli 
Lilly and Icos Corp. for alleged infringement of its Viagra patent while the USPTO 
reexamines the Viagra patent. See Pfizer Faces Setbacks in Patent Battle over Viagra, 
supra note 259. 
 379 See supra note 309. 
 380 See supra note 306 and accompanying text. 
 381 See supra note 174 and accompanying text. 
 382 See Arriola, supra note 220. 
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the Opposition Division desires to give each party the full 
opportunity to present its comments on all important issues and to 
take account of every relevant document, argument, or piece of 
evidence, even if they are submitted late.383  Thus, to make a post-
grant invalidation procedure a true alternative to costly and lengthy 
litigation, it is critical to balance the quality and efficiency of the 
post-grant reexamination process.384 
E. Frequency of Usage/Popularity 
“No post-grant [patent invalidation] procedure will be 
successful unless it is used.”385  As Table 1 shows, the frequency 
of the usage of the SIPO invalidation procedure, at about 2%, is 
low when compared to that of the EPO and the projected rate of 
usage of the invalidation trial at the JPO.386  The reason for this 
lower rate of use, however, may at least in part have to do with 
China’s still developing IPR system and the public’s still growing 
consciousness of IPR protection.  With both the number of patent 
grants and the number of patent infringement suits growing rapidly 
each year, it would not be surprising to see an increase over time in 
the percentage of granted patents that are subject to invalidation 
challenges. 
The EPO opposition procedure is the most frequently used 
among the invalidation systems of the four Patent Offices, with a 
rate of 6–8% of granted patents.387  Despite the length of time it 
takes for a final decision, the EPO opposition procedure is 
preferred over individual national proceedings because the 
opposition decision will have effect in all designated States.388  
Moreover, the EPO panel conducting the opposition consists of 
members who are technically-qualified, as compared to judges 
 
 383 See id.; see also supra notes 220–23 and accompanying text. 
 384 Despite the relatively lengthy EPO opposition procedure, it is the mostly heavily 
used patent invalidation process among the four patent offices, largely due to the effect of 
an EPO opposition decision in all designated member states. See infra Part IV.E. 
 385 See FTC Report, supra note 17, Executive Summary, at 20. 
 386 See supra note 144 and accompanying text. 
 387 See supra notes 143, 190, 244, 308–09 and accompanying text. 
 388 See Arriola, supra note 220; see also supra note 231 and accompanying text. 
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who preside over national proceedings and are essentially trained 
only in the law.389 
Interestingly, one commentator further observes that: 
[D]ifferent attitudes regarding the use of the opposition 
procedure may affect its eventual use by a third party.  On 
the one hand, companies based in countries which have 
long been familiar with opposition procedures, e.g. 
Germany, view opposition as an extension of examination 
in order to limit a competitor’s right while involving only a 
reasonable amount of effort.  Consequently, the procedure 
is viewed not as an act of aggression but rather as a method 
of defining a competitor’s territory.  . . .  On the other hand, 
a different attitude is evident by companies based in other 
countries where oppositions were not the norm prior to 
joining the EPC.  Because such parties view opposition as 
tantamount to legal action or an act of aggression against 
the patentee, their use of the opposition procedure is 
minimal.390 
According to this observation, one might expect that the same 
EPO opposition system would be used less frequently in China and 
Japan, where people have been considered to be traditionally less 
litigious than Western people.391 
The JPO trial for invalidity is expected to be used fairly 
frequently, at about 4%, based on past experiences with the 
previous post-grant opposition and invalidation procedure.392 
The reexamination procedure of the USPTO, in stark contrast 
with that of the EPO, shows a strikingly low frequency of use, with 
less than 0.2% of the granted patents subjected to reexamination.393  
Moreover, the patent owner files 43% of the reexamination 
 
 389 See Arriola, supra note 220. 
 390 See id. 
 391 See, e.g., FRANK K. UPHAM, LAW AND SOCIAL CHANGE IN POSTWAR JAPAN 1, 299 n.1 
(1987).  Both the Chinese and Japanese societies are deeply influenced by the Confucian 
ideals of social harmony. See id. at 1. 
 392 See supra note 190 and accompanying text. 
 393 See supra notes 308–09 and accompanying text. 
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requests.394  The main reason for this low usage seems to lie in the 
U.S. reexamination system itself, rather than with any cultural 
explanation. 
There are numerous roadblocks for a third-party requester of 
patent reexamination in the U.S., including, as discussed above, 
very limited grounds for reexamination, no oral proceedings for the 
third-party requester, and the need to reveal the identity of the 
party of true interest requesting an inter partes reexamination.395  
Additionally, the estoppel rule prohibiting a third-party requester 
from using the same art in later litigation has significant deterring 
effect.396  Another factor disfavoring reexamination may be that 
third-party challengers lack confidence in the system because it 
does not employ a panel of highly experienced examiners for the 
reexamination.  Thus, third-party competitors in the U.S. may 
choose to challenge the patent’s validity in courts, but only if they 
are allowed to do so by the patent owner, i.e., after being sued by 
the patent owner for infringement.397  And if litigation does occur, 
it typically costs millions of dollars and takes years to resolve.398 
The above comparative analysis indicates that, while the post-
grant patent invalidation system in China is similar to those of the 
EPO and the JPO in most aspects, it is very different from that of 
the USPTO, which has not been successful, as evidenced by its 
conspicuously low frequency of use.  There have been numerous 
proposals for reforming the U.S. reexamination system (including 
the new inter partes reexamination) towards an administrative 
system that resembles those of the EPO, JPO, as well as SIPO.399  
 
 394 See supra note 307 and accompanying text. 
 395 See supra note 281 and accompanying text. 
 396 See supra notes 300–02 and accompanying text. 
 397 See FTC Report, supra note 17, Executive Summary, at 6. 
 398 See id. 
 399 See generally FTC Report, supra note 17, ch. 5, pt. III; USPTO, 21st Century 
Strategic Plan, Post-Grant Review of Patent Claims (Apr. 2, 2003), 
http://www.uspto.gov/web/offices/com/strat21/action/sr2.htm (last visited Oct. 29, 2004); 
Janis, supra note 17; Kristen Jakobsen Osenga, Rethinking Reexamination Reform: Is it 
Time for Corrective Surgery, or Is it Time to Amputate?, 14 FORDHAM INTELL. PROP. 
MEDIA & ENT. L.J. 217 (2003); Mossinghoff & Kuo, supra note 150; Allan M. Soobert, 
Breaking New Grounds in Administrative Revocation of U.S. Patents: A Proposition for 
Opposition—and Beyond, 14 SANTA CLARA COMPUTER & HIGH TECH. L.J. 63 (1998). 
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Obviously, if a global patent system is ever to become a reality,400 
the U.S. patent reexamination system must come closer to the 
practice of the rest of the world. 
CONCLUSION 
Patent law must strike a delicate balance between granting 
monopoly rights to inventors and protecting the public from the 
anti-competitive effects of monopolies.401  A functional post-grant 
patent invalidation system that improves the quality of patents is 
one of the best means for achieving this balance.402  In an effort to 
improve its economy and to comply with the TRIPS requirements 
as a member of the WTO, China has been actively improving its 
patent law system, including the post-grant patent invalidation 
procedure. 
For those who are unfamiliar with the development and current 
status of China’s IP law and practice, it may come as a surprise 
that the Chinese post-grant patent invalidation system closely 
resembles the relatively successful invalidation procedures of the 
European Patent Convention and Japan.403  The recently adopted 
practice of posting detailed decisions on the Internet has increased 
the transparency of judicial resolution of IPR cases, including 
 
 400 A global patent system is now a 120-year dream. See Michael N. Meller, Planning 
for a Global Patent System, 80 J. PAT. & TRADEMARK OFF. SOC’Y 379, 379 (1998). 
 401 See Arriola, supra note 220. 
 402 See id. 
 403 It will be less of a surprise if the reader learns about the serious effort the Chinese 
have taken to set up and improve their IP system.  For example, to figure out how to 
construct its first Patent Law of March 12, 1984, China dispatched delegations to major 
industrial nations, including the United States, West Germany, and Japan; to relatively 
prosperous socialist states such as Romanian and Yugoslavia; and to major international 
intellectual property organizations such as the World Intellectual Property Organization 
(WIPO) and the UN Education, Science and Cultural Organization. See ALFORD, supra 
note 18, at 69.  “The full patent laws of some 35 jurisdictions were translated and those of 
more than 100 other nations summarized,” the experience of Hong Kong was studied, 
and inside China, the views of cadres in factories, scientific research institutes, 
universities and government agencies were solicited. Id.  “In the end, the drafting 
committee spent more than five years, during which it went through some 20 drafts prior 
to finally producing a bill,” which was passed only after the National People’s Congress 
(NPC) further amended it. Id. 
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appeals from SIPO’s patent invalidation decisions.404  These may 
be reasons to have more confidence in a fair resolution of Pfizer’s 
pending appeal of the invalidation of the Viagra patent.  
Regardless of the outcome of the appeal, an important lesson from 
the Viagra case is that, in anticipation of likely challenges to the 
validity of economically significant patents, multinational 
companies should understand the law and practice of the Chinese 
post-grant patent invalidation system, and adopt best practices in 












 404 See supra note 13 and accompanying text. 
SUN 1/25/2005  6:16 PM 
2004] POST-GRANT PATENT INVALIDATION 331 
TABLE 1.  KEY FEATURES OF POST-GRANT PATENT INVALIDATION 
SYSTEMS IN CHINA AND THE TRILATERAL PATENT OFFICES 
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